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ABSTRACT 
 
 
Animal cell culture has provided several beneficial improvements in the field of 
biotechnology. Nowadays, the engineers have focused their work in the optimization 
of cell cultures techniques. One important tool used is the simulation by computer 
since it is inexpensive, requires less time than other methods and it is a simple way 
of understanding the behaviour of the cells in a culture. 
 
This Thesis worked in the design of one simulator that describe the evolution over 
time of the extracellular metabolites and cell growth of CHO culture. A model that 
was designed using the concept of metabolic reaction network and the assumption 
of pseudo-steady state was checked and validated using diverse set of experimental 
data. In order to trigger different metabolic routes in the cells, these experiments 
were carried out varying amino acid composition in the medium. 
 
The metabolic reaction network was simplified and consisted in 38 reactions. The 
set of experimental data was simulated using a graphical interface design in the 
present Thesis. The model succeeded since the results were very satisfactory. The 
error was, in general, small and it was checked that the system could also detect the 
different metabolic pathways that the cells follow when the initial conditions are 
modified in many metabolites. The model can also be applied without the 
information of all the essential amino acids, obtaining highly satisfying results as 
well. 
 
 
 
 
 
ABBREVATIONS 
 
 
aa  Amino acid 
AAA Amino Acid Analysis 
AABA Amino Butyric Acid 
AcCoA Acetyl Coenzye A 
Ala Alanine 
Arg Arginine 
Asn Asparagine 
Asp Aspartate 
ATP Adenosine triphosphate 
CHO Chinese Hamster Ovary cells 
CO2 Carbon dioxide 
CT Centrifuge Tube 
Cys Cysteine 
DMEM Dulbecco's Modified Eagle's 
medium 
DMEM/F12 Dulbecco's Modified 
Eagle's Medium: Nutrient Mixture F-
12 
Eaa Essential amino acids 
EFM  Elementary Flux Mode 
EP Extreme Pathway 
FBA Flux-balance analysis  
Gln Glutamine 
Glu Glutamate 
Glc Glucose 
Gly Glycine 
G6P Glucose-6-Phosphate 
His Histidine 
 
 
 
 
 
HCL     Hydrochloric acid 
HPLC High Pressure Liquid 
Chromatography 
Ile Isoleucine 
Lac Lactate 
Leu Leucine 
LR Linear Programming 
Lys Lysine 
MEM Eagle’s Minimal Essential 
medium 
Met Methionine 
MFA Metabolic flux analysis 
MPA Metabolic Pathway Analysis 
NaOH Sodium hydroxide 
NH4 Ammonia 
O2 Oxygen 
Phe Phenylalanine 
Pro Proline 
Ser Serine 
SF Serum-free 
SucCoA Succinyl Coenzyme A 
TCA Trichloroacetic acid 
Thr Threonine 
Trp Tryptophan 
Tyr Tyrosine 
Val Valine 
KG Alpha-ketoglutarate 
 
 
 
NOMENCLATURE 
 
 
aij Elements of the macroscopic stoichiometric matrix 
bj flux that produce and consume the metabolite in the reaction j 
Ci Concentration of the metabolite I [ M] 
Cin  Inflow concentration of the metabolite [mol/l] 
Cout  Outflow concentration of the metabolite [mol/l] 
D Dilution factor (dimensionless) 
E Null space 
Fin  Inflow volume per day [l/h] 
Fout  Outflow volume per day [l/h] 
Km Michaelis constant [ M] 
MVC Million viable cells 
N Number of reactions of the metabolic reaction network 
NS Number of samples 
p Number of extracellular metabolites 
Qi  Consumption/production rate of the metabolite I [mol/l·h] 
qi Specific consumption/production rate of metabolite I [nmol/MVC·day] 
Si,j  Stoichiometric coefficient of the metabolite i in the reaction j  
t  Number of intracellular metabolites 
V Volume [l]
vj Specific flux of the reaction j  
Xv Cell density [MVC/mL] 
max,j Maximal kinetic rate of the reaction j  
 
Matrices and vectors 
 
Aext Extracellular stoichiometric matrix 
Aint Intracellular stoichiometric matrix 
Amac Macroscopic stoichiometric matrix 
Ared Stoichiometric matrix of the reduced system 
b Vector of the reaction fluxes 
  
C Concentration of the metabolites 
Q Vector of the consumption/production rate of the metabolites 
qest Specific consumption/production rate of the extracellular metabolites 
qint Specific consumption/production rate of the intracellular metabolites 
S Stoichiometric matrix 
v  Vector of specific fluxes 
w Vector of the macroscopic specific rate fluxes 
 Vector of the extracellular concentration  
max Vector of the maximal kinetic rates of the reactions 
 Matrix elements qij
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1.  INTRODUCTION 
 
 
Animal cell culture has a special interest in the industry of biotechnology since the 
ability to grow animal cells in vitro has provided different advances in the fields of 
biology and medicine [1].  They have been used to study the physiological and 
biochemical properties of the cells as well as to test the effects of drugs and 
vaccines, to produce artificial tissue for implantation and to synthesize valuable 
products from large-scale cultures [2]. 
 
Due to their importance, the engineers have focused their efforts in the study and 
optimization of cell cultivation techniques. There are different methodologies that 
engineers use to accomplish this goal. However, most of the techniques employed 
were expensive and time-consuming.  Hence the introduction of simulation by 
computer has helped the work of engineers. 
 
These simulators use mathematical models to describe the cells and the interaction 
of the different components in cell cultures. They reproduce the behaviour of cell 
culture in a more efficient way that in real experiments, since it is faster and it does 
not require a high cost. Moreover, new devices and techniques were designed 
thanks to the introduction of the simulators. One example is the software sensors, 
which are more reliable than the hardware ones.  
 
1.1. Aim of the Thesis 
 
The aim of this Thesis is the study of the performance of a dynamical model already 
done, which can predict the behaviour of CHO cells in a culture over time. The model 
was studied, validated and verified using different experiments of CHO culture 
under different conditions (Fig. 1.1). 
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Figure 1.1. Strategy of the Thesis 
 
The concept of metabolic reaction network and the assumption of pseudo-steady 
state are used in the design of the model. The variables of the model are the major 
energy source, glucose and glutamine, amino acid and cell density, which are the 
only parameters that are measured in a cell culture. 
 
Experimental data will be obtained doing different cell culture with different 
environmental conditions.  
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2. ANIMAL CELL CULTURE 
 
 
Ross Harrison was the first person that succeeded in the culture of animal cells in 
1907 [3].  But the scientists did not start to use them as an important tool until the 
50’s and its commercialization still took nearly two decades to carry out [4]. Since 
then, several advances have been made within different applications and fields like 
the development of new vaccines and drugs [3]. 
 
Animal cell culture consists in the growth and proliferation of cells outside the 
tissue using a mixture of different components. The mixture is called medium and 
its composition is essential in the good performance of the culture [4]. 
 
A medium has to contain all the components necessary for the nutrition of the cells: 
vitamins, amino acids, lipids, nucleic acid precursors, carbohydrates, trace elements, 
salts, bulk ions and often growth factors and hormones. Components that ensure 
constant pH levels are also necessary [5]. Historically, the media were designed 
using a base medium supplemented with several factors [4]. These factors included 
serum or other blood products lipids as well as embryo extracts or yeast extracts. 
The most common one was the serum. It contained the necessary concentration 
factors to provide growth and proliferation of the cells like proteins, trace elements, 
growth factors, vitamins, etc. [5].  Eagle’s minimal essential medium (Eagle’s MEM 
or MEM) and MEM modified by Dulbecco (Dulbecco’s Modified Eagle’s Medium, 
DMEM) were typical base medium. They are still used nowadays to keep primary 
cell cultures and cell lines [4]  
 
However, the use of serum as a supplement in the base media carried a high cost 
and several technical drawbacks. These technical disadvantages include the high 
risk of contamination (e.g. viruses), the undefined nature of serum and variations in 
the serum composition due to seasonal and continental variations. [6]. The latter 
case produces batch-to-batch variations, which causes phenotypical differences in 
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the cell cultures and as a consequence the results could differ. Moreover, some 
ethical issues, such as the unnecessary suffering of the animals during serum 
extraction, have created difficulties in the utilization of such media [4]. 
 
As a consequence, nowadays the efforts of the scientists are focused on the creation 
of serum-free media. The new design uses the base media described above with 
supplementation of different components. Examples of such supplements are: 
hormones, growth factors, attachment factors, lipids, protease inhibitors, protein 
hydrolysates and proteins. It is also common to add some amino acids. Generally, 
the base media contain the essential amino acids1 and then additions of nonessential 
amino acids2 are done.  The difference between essential and nonessential amino 
acids is that the cells cannot biosynthetise the essential amino acids and the cells 
need them to grow [4]. 
 
An important example is the Ham’s F12 medium, which contains lipids, nucleic acid 
derivatives, vitamins, non-essential amino acids and small concentrations of the 
essential amino acids and sugar [5]. 
 
The use of serum-free media has provided other advantages such as an increased in 
the cell growth and its productivity, more consistent performance, precise 
evaluations of cellular function and a better control over physiological 
responsiveness [7]. 
 
There are some aspects that must be taken into account in the design of serum-free 
media. The first one is that it does not exist a universal media that can be used in all 
cell types; so different serum-free media have been designed for each cell type [4]. 
And second the cells need some processes to adapt to the new serum-free media 
and the whole process must be monitored and checked carefully since small 
                                                        
1 Arginine, Histidine, Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Threonine, Tryptophan and Valine 
2 Alanine, Asparagine, Aspartate, Cysteine, Glutamate, Glutamine, Glycine, Proline, Serine and Tyrosine 
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undesired changes in the culture conditions, may produce alterations in cellular 
functions  [6]. 
 
Other possible media are animal-free media and protein-free media. The former 
case is similar to serum-free media but the components are derived from non-
animal sources. And the latter case does not use proteins [8]. 
 
2.1. Mammalian cells: Chinese Hamster Ovaries (CHO) 
 
Nowadays, the mammalian cells are one of the most used cell types in biology and 
medicine. Mammalian cells occupy 60% of the current market [9]. Inside this type of 
cells, Chinese Hamster Ovary cells are the most important ones. They are widely 
spread and are used for transfection, expression and large-scale recombinant 
protein production [10]. Almost 70% of the recombinant protein therapeutics 
produced today is from CHO [11]. 
 
This type of cells is generally grown in incubators under specific conditions: the 
temperature is kept around 37 °C with a controlled humidified gas mixture of 95% 
O2 and 5% CO2 [4]. 
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3. METABOLIC REACTION NETWORK 
 
 
Cell metabolism involves thousand of biochemical reactions where the metabolic 
substrates are transformed either in energy or other components [12]. It is 
graphically represented by a metabolic network, which illustrates the different 
biochemical reactions that occur within the cell, together with the reactions that 
happen with the environment that surrounds the cell [13].  
 
The metabolic network consists of nodes, which symbolize the metabolites, and 
edges, which represents the metabolic reactions (Fig. 3.1). The inputs and outputs 
are, respectively, the substrates and the products [14].   
 
 
Figure 3.1. Metabolic reaction network [15] 
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The cells grow as a consequence of the coordinated action of different groups of 
reactions, usually called pathways. Furthermore, each reaction of each metabolic 
pathway occurs according to a given rate, called metabolic flux [16]. The metabolic 
flux of one reaction depends on the concentration of the metabolites involve on it. A 
mass balance can be applied for a given component [17].  It follows from the 
physical law that matter or mass can neither be created nor destroyed for every 
component [18]: 
 
Massin Massproduced Massout Massaccumulated                                     (1) 
 
Since the mass is equal to the multiplication of the concentration times the volume, 
Eq. 1 for one metabolite can be rewritten as follows: 
 
Cin Fin Qi V Cout Fout V
dC
dt
                                              (2) 
 
where 
 Cin is the inflow concentration of the metabolite [mol/l] 
 Fin is the inflow volume per day [l/h] 
 Qi is the consumption/production rate of the metabolite [mol/l·h] 
 V is the volume of the system  (in this case it is assumed that it is constant) [l] 
 Cout is the outflow concentration of the metabolite [mol/l] 
 Fout is the outflow volume per day [l/h] 
 C is the concentration of the metabolite [mol/l] 
 
The consumption/production rate of a component is given by the sum of the 
consumption/production rate of all the pathways in which this component is 
involved weighted by the stoichiometric coefficients Sij. The stoichiometric matrix 
contains the stoichiometric coefficient Sij. The rows of S corresponds to the 
metabolites and the column to the reaction kinetics [19,20]:  
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j
jjiiiii bSQbSbSbSbSQ ,312111                             (3) 
 
where, 
Si,j is the stoichiometric coefficient of the metabolite i in the reaction j and                                
determines the number of moles of metabolite i formed in the reaction j 
bj is the flux that produce and consume the metabolite in the reaction j 
Q is a vector that contains the consumption/production rate of each 
metabolite 
 
Si,j is negative when the metabolite i is a substrate and positive when it is a product. 
And in the same way, Qi is positive when the metabolite is produced and negative 
when it is consumed [19].  It is common to use the cell specific 
consumption/production rate qi instead of the Qi: 
 
qi
Qi
Xv
                                                                         (4) 
 
where Xv is the viable cell density. 
 
In case the culture volume is constant Fin=Fout and the dilution factor D can be 
defined as: 
 
D
Fin
V
Fout
V
                                                                    (5) 
 
It follows, then, from Eq. 2 to Eq. 5 that: 
 
Q q Xv S v Xv
dC
dt
D(Cout Cin )                                       (6) 
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It can be seen that in this case v is the vector of specific fluxes of the biochemical 
reactions and depends only on the concentrations of the metabolites involve in each 
reaction (b
v
X v
). 
 
Eq. 6 can be particularized for different kind of systems: 
 
 Batch process: in this case D is equal to 0: 
 
dt
Cd
X
v
v
SS
SS
q
q
v
MNMM
N
M
1
1
,1,
,11,11




                                     (7) 
 
where M is the number of reactions of the system.  
 
 Perfusion process: in this case the variation of the concentrations over time is 
0, i.e. 
dC
dt
0 , it follows: 
 
v
inout
MNMM
N
M
X
CCD
v
v
SS
SS
q
q
)(1
,1,
,11,11




                               (8) 
 
3.1. Mathematical cell metabolism models 
 
There are diverse techniques that employ mathematical models to describe the cell 
metabolism. Despite each methodology has different aims, uses distinct 
mathematical procedures and is based on different assumptions, all of them exploit 
the stoichiometric matrix to describe the models and assume the quasi-steady state 
[21].  
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The study of the intracellular metabolic fluxes is very important to understand 
better the different pathways interactions and their impact in the whole metabolic 
process [22]. The knowledge of the fundamental metabolism of cells in culture 
under different environmental conditions is indispensable in control strategies, 
media formulations and for the design of bioreactors [23]. 
  
One of the most used methodologies is the called Metabolic Flux Analysis (MFA) and 
has an important importance in metabolic engineering [24,25]. MFA uses the 
available data, which is mainly the extracellular fluxes, to determine the fluxes that 
are not possible to measure, which corresponds to the intracellular fluxes [25]. It is 
also used to estimate the major metabolic pathway fluxes, using material balancing 
[26, 27]. 
 
Even though MFA has been a widely employed methodology, it has some limitations 
[21]. The first one comes directly from the methodology itself since MFA requires a 
lot of measurements to be able to provide results. Unfortunately, the number of 
external measurements is not sufficient and the obtained system is 
underdetermined [28]. Therefore, the solution for the system is not unique. A 
second drawback is that the measurements have a significant error due to the 
imprecision and the insufficiency of the set of available measurements. 
 
Some changes have been made in order to use MFA in either a determined or 
overdetermined system. Among them, there are the addition of metabolic 
theoretical constraints [28], the simplification of the metabolic network by the 
synthesis of a group of reactions into one simple reaction [23,29], making the 
system simpler, or the use of linear algebra or convex analysis to get only the 
solutions that are positive and possible in the system [27, 30]. 
 
Nowadays, it is emerging a new technique called flux-spectrum approach, which is 
employed to obtain the metabolic fluxes over time [31,32].  This technique uses the 
a priori knowledge to introduce reversibility constraints and takes into account the 
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uncertainty of the measured fluxes [32]. This approach can also estimate the non-
measured fluxes even when the system is undetermined and the obtained results 
are more reliable in determined system than in other techniques [33]. 
 
Another methodology that is used when the metabolic flux distribution is 
undetermined is the flux-balance analysis (FBA). It is based on linear programming 
(LP), which optimize an objective function using the most effective and efficient 
paths through the network [34].  Some examples of the objective function are the 
maximization of biomass and ATP production [28,34]. The advantage of such 
technique is that it is possible to obtain quantitative measurements of the behaviour 
of the network with a minimum biological knowledge and a small amount of data 
[28]. 
 
Metabolic Pathway Analysis (MPA) is another flux-bases analysis method. It works 
with the concepts of elementary flux modes (EFM) and extreme pathways (EPs) [36-
38].  Both concepts are similar since EPs are part of the EFM. MPA studies the 
properties that the stoichiometric gives, observing all the feasible biochemical 
network states in the optimal solution space [39].  
 
The concept of EFM is a very important concept since it can be used to reduce a 
complex system into a simpler network, with a minimum number of reactions, as it 
was done in [27]. For that reason, in this Thesis it was decided to follow the 
methodology made by Joan Gonzalez Thesis [40]. It uses elementary flux analysing 
to calculate a macroscopic reaction. Following, the calculated macroscopic reaction 
is used to create a simplified system that will be used to predict the 
production/consumption rates. 
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3.2. Pseudo-steady state assumption 
 
The common assumption in all the studies, the pseudo-steady state, declares that 
the intracellular metabolites in growing cells are in quasi-steady state. Therefore, 
the net sum of the production and consumption fluxes of these intracellular 
metabolites weighted by their stoichiometric matrix coefficients are zero [16]. It 
means that the kinetic reactions inside the cells are so much faster, reaching the 
steady state in a shorter period of time, than the reactions that involve extracellular 
metabolites [27]. 
 
An algebraic relation expresses this assumption: 
 
Aint v 0                                                                        (9) 
 
where Aint corresponds to the stoichiometric matrix of the intracellular metabolites. 
 
 
This expression can be introduced in Eq. 3: 
 
tp
p
p
tptptp
ppp
Mppp
M
p
v
v
v
v
SSS
SSS
SSS
SSS
q
q










1
1
1,1,1,
1,11,11,1
,2,1,
,12,11,11
0
0
                                     (10) 
 
where p is the number of extracellular metabolites and t the number of intracellular 
metabolites. 
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Or, 
  
S v
qint
qext
0
qext
Aint
Aext
v                                                      (11) 
 
where qint and qext are the vectors of the specific consumption/production rates of 
the intracellular and extracellular metabolites respectively and Aint and Aext are the 
stoichiometric matrices of the intracellular and extracellular components. 
 
The subdivision of the intracellular and extracellular systems gives the following 
equations: 
 
q
int
Aint v 0 qext Aext v                                           (12)  
 
3.3. Macroscopic matrix 
 
A macroscopic model is used when the only available data, besides the cell density, 
are the measurements of the extracellular metabolites. Thus, the input data of the 
system is: 
 
 Cell density (Xv): number of alive cells in the culture [MVC/mL]. In the case 
of the cell density, the concentration is computed multiplying the Xv by 1000. 
In that case the units are 103 cells/mL. 
 Viability: rate of living cells to total number of cells [%]. 
 Ci: concentration of the extracellular metabolite i [ M] 
 qi: cell specific consumption/production rate of the extracellular metabolite i 
[nmol/MVC·day]. 
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Since, the way that the substrates are converted into products is unknown, the 
system is considered as a black box that catalyses the conversion of substrates into 
products [14]: 
 
     Extracellular        Extracellular 
       Substrates     Products 
 
Figure 3.2. Metabolic system seen in a macroscopic point of view 
 
The first stage of this approach is the calculation of the EFM, set of biochemical 
reactions that starts in one or several substrates and ends in one or several products 
[27]. In other words, an EFM is a vector that fulfils Eq. 8.  
 
According to linear algebra, the set of EFM can be expressed using the concept of 
null space (E).  All the possible solutions and their corresponding flux distributions 
can be expressed using the null space. The null space is a basis, a minimum number 
of linear independent vectors that fulfils Eq. 8 and such that: 
 
Aint E 0                                                                 (13) 
 
where dimension of E is obtained using the Rank Theorem of linear algebra [39]: 
 
dim( E) N Rank(Aint )                                                      (14) 
 
where N is the number of reactions of the system. 
  
In order to compute the EFM, the Metatool can be used. It is a very simple tool and it 
is widely used in the computation of metabolic flux analysis [36,41]. The only 
parameters that Metatool needs is the stoichiometric matrix of the intracellular 
metabolites (Aint) and a vector of length equal to the number of reactions, which 
expresses if the reaction is reversible or not. 
Intracellular 
metabolites 
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Nevertheless, it has been tested that Metatool has a problem when it has to compute 
the EFM of the reactions that involve only extracellular reactions. These reactions 
are expressed in Aint as a column of 0 in all the positions. Normally, the 
corresponding EFM is expressed as a vector containing 0 in all the positions, except 
the position of the reaction, which contains a 1. The problem arises in the case that 
the reaction is reversible where an EFM should contain a -1 in the position of the 
corresponding reaction. It was decided to add them manually in the computation of 
the null space. 
 
Once the null space is calculated, the macroscopic reaction can be computed in a 
matrix called Amac as: 
 
Amac Aext E                                                         (15) 
  
The dynamical model of the extracellular reactions can be written, using Eq. 7 for 
the extracellular metabolites, as: 
 
d
dt
Amac w Xv                                                       (16) 
 
where  are the extracellular metabolite concentrations and w corresponds to the 
vector of the specific rates of the macroscopic reactions.  From Eq. 11, Eq. 15 and Eq. 
16 it can be found the relation between v fluxes and the macroscopic specific rates 
w: 
 
d
dt
Amac w Xv Aext E w Xv Aext v Xv v E w                   (17) 
 
And introducing this relation in Eq. 12: 
 
qext Aext v Aext E w Amac w                                         (18) 
 23 
The specific rates of the reactions can be obtained using kinetics. In this case, the 
Michaelis and Menten model was applied [42].  The model shows the relation 
between the substrate and the specific rate of the reaction in an enzyme using the 
following formula: 
 
v max
[S]
Km [S]
                                                             (19) 
 
where max corresponds to the maximal kinetic rate when the enzyme is saturated of 
substrate, [S] is the concentration of the substrate of the enzyme and Km is the called 
Michaelis constant or half saturation constant. Km is equal to the value of the 
substrate concentration where the reaction is half the maximal kinetic rate that the 
enzyme can reach. 
 
One important aspect that has to be mentioned is that the Michaelis and Menten 
kinetics assumes that all the reactions are irreversible. So, the information of 
reversibility will be in the EFM, i.e. two reactions are considered one in each 
direction. 
 
Eq. 19 can be applied when there is more than one substrate involve in the enzyme, 
as [16]: 
 
v
max [S]i
i
(Km,i [S]i )
i
                                                       (20) 
  
where  is the corresponding stoichiometric value of the substrate i in the reaction 
in question.  
 
The w rates can be computed, applying Eq. 20 and taking into account that in this 
case, the reactions are seen from a macroscopic point of view: 
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w j j
c i
a ' i , j
(K i c i)
a ' i , j
i
                                                     (21) 
 
where ci corresponds to the extracellular substrates of the macroreaction j. 
 
Now all the parameters are known except the maximal kinetic rates j. According to 
that, it can be created a linear system that related the specific 
consumption/production rates with the maximal kinetic rates, introducing Eq. 21 in 
Eq. 18: 
 
N
i
Na
ii
a
i
Np
i
a
ii
a
i
p
i
a
ii
a
i
i
a
ii
a
i
p
cK
c
a
cK
c
a
cK
c
a
cK
c
a
q
q
Ni
i
i
Ni
Ni
i
i





1
'
'
,'
'
1,
'
'
1,1'
'
1,1
1
)(
'
)(
'
)(
'
)(
'
,
1,
1,
,
,
1,
1,
                 (22) 
 
where aij are the elements of Amac. 
 
The above system is applied, then, to each sample of the experiment that is been 
analysing.  Consequently and after applying the above system to all the samples, the 
final system can be written as: 
 
B
B
B
q
q
q
q
q
NNS
NSp
NS
p




11
,
,1
2,1
1,
1,1
                                          (23) 
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where NS is the number of samples of the experiment,  is the matrix of the 
elements qij and Bi is the matrix of the linear system in Eq. 20 applied for each 
sample. 
 
In order to calculate the maximal kinetic rates , the first algorithm that was chosen 
was the non-negative least-squares where the next function had to be optimize: 
 
z min B
2
2
where 0                                            (24) 
 
 
However, this gave a significant error between the calculated values and the 
obtained ones using Eq. 24. For that reason, a second function was chosen to obtain 
better results: 
 
z min Bnorm norm
2
2
where 0                                      (25) 
 
where Bnorm and Qnorm are the normalization of B and Q by the average of the set of 
consumption/production rates of each metabolite. Moreover, each row of B and Q, 
which corresponds to specific metabolites, are divided by the average of the 
consumption/production rates obtained in all the samples of this specific 
metabolite. 
 
Using the non-negative least-square, it was checked from [40] that in order to 
assure an optimal solution for , the system has to be overdetermined. This is a 
typical condition that has to be satisfied in least squares methodologies [43]. In this 
case, to fulfil the condition, the matrix B has to have more rows than columns: 
 
N. extracellular metabolites
( p )
N. of samples
(NS )
N. of reactions
(N )
               (26) 
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It could be observable that normally there were several maximal kinetic rates j that 
were zero and these extracellular reactions do not affect the estimated rates of the 
model. For that reason, it was decided to design a reduced system where only the 
reactions with a maximal kinetic rate above zero are taken. The new matrices 
obtained are Ared and red and they will be used in the estimation of the parameters 
in the model above described. 
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4. MATERIALS AND METHODS 
 
4.1. The system 
 
The metabolic network and its corresponding stoichiometric matrix used in this 
project were taken from [40]. This model took as a starting system the one made by 
[8], which used the experimental data from different experiments [29,44] to 
construct the biochemical network, considering the most relevant metabolic routes 
for animal cells cultured in vitro. Following, some simplifications, corrections and 
adjustments were made to arrive to a simpler model: 
 
Table 4.1. Biochemical network of CHO cells3 
 
R1 Glc  G6P 
R2 G6P  2·3phosphaglycerate 
R3 3phosphoglycerate Pyr 
R4 Pyr  Lac 
R5 Pyr  AcCoA + CO2 
R6 AcCoA + Oxal  Cit 
R7 Cit  KG + CO2 
R8 KG  SucCoA + CO2 
R9 SucCoA  Suc 
R10 Suc  Mal 
R11 Mal  Oxal 
R12 Mal  Pyr + CO2 
R13 Thr  Gly + AcCoA  
R14 Trp  Ala + NH4 +2·AcCoA 
R15 Lys  NH4 + KG 
R16 Ile  Glu + AcCoA + SucCoA  
R17 Leu  2·AcCoA + 2·CO2 
R18 Tyr  Mal + Oxal + CO2 
 
R19 Ser + Met  Cys + NH4 
R20 Val  SucCoA + KG 
R21 Glu + Oxal  Asp + KG 
R22 Glu   KG + NH4 
R23 Glu + Pyr  Ala + KG 
R24 Cys  Pyr 
R25 Ser  NH4 + Pyr 
R26 Gly  NH4 + CO2 
R27 Ser + Thr  SucCoA 
R28 Glu + 3phosphoglycerate  Ser + KG 
R29 Ser  Gly 
R30 Phe  Tyr 
R31 Asn  Asp + NH4 
R32 Gln  Glu + NH4 
R33 Arg  Glu 
R34 Glu  Pro 
R35 His  Glu + NH4 
R36 Gln + Asp  Glu + Asn 
 
R37 0.0208·Glc + 0.0377·Gln + 0.0006·Glu + 0.007·Arg + 0.003·Hist + 0.0084·Ile + 
0.0133·Leu + 0.0101·Lys + 0.0033·Met + 0.0055·Phe + 0.008·Thr + 0.004·Trp + 
0.0096·Val + 0.0133·Ala + 0.026·Asp + 0.0004·Cys + 0.0165·Gly + 0.0081·Pro + 
0.0099·Ser + 0.0077·Tyr  Biomass 
 
                                                        
3 R4, R21, R22, R23, R29, R30, R31, R32 and R36 are considered reversible 
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These modifications can be summarized in the following statements [41]:  
 
 Some reactions and metabolites were discarded. This affected, mainly, the co-
metabolites (ATP, ADP, NAD…) and the mitochondrial transport, considering 
that the metabolites inside and outside the mitochondria were the same 
metabolite. 
 
 Some reactions were modified or corrected and others were added by our group 
since they occur in mammals and were missing in Altamirano model. These 
adjustments affected the reversibility of some reactions as well as the addition 
and elimination of some metabolites in some reactions. 
 
 The biomass was described as only one reaction, using the same procedure as in 
[23].  
 
 CO2 was considered as an external metabolites and it is not used in the 
mathematical model since it is a final product and therefore does not affect the 
other reactions. 
 
The metabolites of the system can be classified as: 
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Figure 4.1. Classification of the metabolites in the system 
 
The above system did not consider the state where the cells died and it was only 
possible to use it in the growing phase of the cells. For that reason, a new reaction 
was added that took also into account the death phase of the cells (Cd).  
 
Cv Cd  
 
where Cv is the cell density [MVC/mL]. 
 
 
Metabolites 
Subs./Prod. 
External met.  
Internal met. 
Substrates Products 
Arginine 
Glucose 
Histidine 
Isoleucine 
Methionine 
Leucine 
Lysine 
Phenylalanine 
Proline 
Threonine 
Tryptophan 
Valine 
 
Biomass 
Lactate 
Alanine 
Asparagine 
Aspartate 
Cysteine 
Glutamate 
Glutamine 
Glycine 
NH4 
Serine 
Tyrosine 
AcCoA 
Citrate 
CO2 
G6P 
Malate 
Oxalate 
Pyruvate 
Succinyl 
SucCoa 
KG 
3-phos. 
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Cd can be calculated using the definition of the Viability: 
 
Viability
Cv
Ctot
Cv
Cv Cd
Cd
Cv(1 Viability)
Viability
                      (27) 
 
where Ctot=total number of cells (MVC/mL) and Cd has the same units as Cv 
[MVC/mL]. 
 
For computation of the concentration of the cell death, the methodology is the same 
as in the case of cell density. So, this concentration is obtained multiplying the 
corresponding cell density by 1000 [103 cells/mL].  
 
Regarding the Michaelis constants (Km), in absence of their value, the KTH Division 
of Bioprocess suggested the following values based on the order of magnitude of the 
concentration of these components: 
 
Table 4.2. Michaelis constants of extracellular metabolites 
Km [ M] 
Alanine 100 NH4 300 
Arginine 300 Lactate 300 
Asparagine 100 Leucine 100 
Aspartate 100 Lysine 100 
Cysteine 100 Phenylalanine 100 
Glucose 300 Proline 100 
Glutamate 100 Serine 300 
Glutamine 100 Threonine 100 
Glycine 100 Tryptophan 100 
Histidine 100 Tyrosine 150 
Isoleucine 100 Valine 100 
Methionine 100 Bio./C. Death 100 
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4.2. Experiment 
 
The experiment consisted in cell culture of suspended GFP K4 CHO cells, which were 
carried out in 50 mL filtered cap centrifuge tubes with a working volume of 5 mL. 
The cells were given by Gemma Ruiz. 
 
A set of different centrifuge tubes, where each tube had different concentrations of 
amino acids, was performed. Thus, the different behaviour of the system could be 
analyzed by looking at the distinct reaction pathways in the metabolic network in 
different conditions. 
 
The cultivation of each centrifuge tube was carried out during several days until the 
cells attained steady state. The cells needed some days to adapt to the new 
conditions.  In normal situations, the steady state was reached after two or three 
days of the beginning of the experiment.  
 
Since the Amino Acid Analysis (AAA) was performed during steady state, the 
experiment could last as long as desired to obtain satisfying results and in a same 
run the results taken every day were (in principle) repeat of the results obtained the 
other day after the steady state was reached. Increasing the number of data points 
per run allowed to improve the quality of the information. The duration of the 
experiment depended also on how the cells grew. 
 
4.3. Media preparation 
 
The media, which were used in this project, had been developed in a project in the 
KTH Division of Bioprocess by Gemma Ruiz. The main objective of this project was 
to develop a medium whose composition was perfectly known and had good 
performance, meaning that the cells would grow twice every day. 
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The project in question took as a base medium the composition of the known 
medium DMEM/F12. Then, additions of components already present or new 
components were done in order to improve the performance of the original 
medium. The additions were suggested and tested by Gemma Ruiz before they were 
accepted.   
 
A first experiment, called RMB03.2, was done using a medium called SF10 (see 
Appendix B for its composition). The results, as it can be seen in the following 
section, were not as good as expected, so a second medium called SF14 that has a 
different composition than SF10 (see Appendix B) was used.  
 
The main differences between these two medias are the following ones: 
 
 The media contained different kind of insulin. SF10 contains pancreatic 
bovine insulin, while SF14 contains recombinant human insulin. 
 SF14 contained Hypoxanthine and Thymidine, which are compounds that 
help to the duplication of the cells DNA. 
 And other components whose concentrations were changed between the 
first and second media.  
 
Table 4.3. Differences between media 
 Concentration (mg/L) 
 SF10 media SF14 media 
Ferric citrate - 0.25 
Hypoxanthine - 20 
Insulin 15 5 
Myo-inositol 12.6 70.6 
Nicotinamide 2.02 6.02 
Putrescine 0.081 1.031 
Thymidine - 5 
 
Andreas Andersson performed the first experiment during the realization of his 
Thesis. The second experiment was performed during the present Thesis.   
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Once the final composition of the medium was decided the following step was the 
preparation of the medium itself.  The mixture of the different components had 
some problems because not all the components could be added directly to the 
volume established either because the concentration of the different components 
were impossible to weight with the scales available in the department or because 
they were not all soluble in the same bases.  
 
Hence, in order to avoid these problems most of the components were prepare in 
stock solutions before they were added to the final medium in dH2O, HCL 1 mM, 
NaOH 1 mM or ethanol 99%. A small amount of components were added directly to 
the medium.   So, as explained before, all the components were added to the final 
volume except the amino acids. Following this, the base medium was aliquoted in 
small volumes and the specific concentrations of the amino acids were added.  
 
During the preparation of the medium, the pH and the osmolarity were controlled 
due to the fact that the cells are only able to grow in specific conditions. In the 
present case, the range of the pH was between 6.9 and 7.1 and for the osmolarity 
between 290 and 340 mOsm/Kg. The pH could vary significantly due to the addition 
of basic stock solution or acidic stock solutions. The medium contained phenol red, 
pH indicator. So when the medium turned yellowish the pH level was low and when 
it became pink/purple the pH was too high. In the first case the pH was increased 
adding some drops of HCL 1mM and in the second case adding some drops of NaOH 
1mM.  
 
4.4. Methodology 
 
The main idea of the experiment was to inoculate the cells at a specific cell density 
(Cv) and renew the culture medium every day by withdrawing used medium and 
adding with fresh medium, while maintaining the same volume and Cv.  According 
to that, the methodology in the first experiment was as follows: 
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Day 1. The cells were inoculated at cell density 1 MVC/mL in a volume of 5mL 
medium was added. Then the tubes were put in the incubator (36,5 °C, 200 rpm, 5% 
CO2). 
 
Day 2. One sample was taken to determine the cell density and growth rate (in a 
perfect case the cell density had to be twice the previous day). Following, a 
calculated volume of cell broth was discarded in order to have a cell number in each 
tube of 5 MVC/mL. The remaining culture was centrifuged 5 min. at 1000 rpm (100 
g.). Finally, the supernatant was aliquoted and stored at -20 and fresh medium was 
added to obtain a final volume of 5 mL, giving a cell density of 1 MVC/mL. 
 
Following days. The same procedure as day 2. 
 
The Bioprofile was used to determine the cell density and viability as well as the 
concentration of some metabolites: Glc, Lac, Gln and Glu. The rest of the 
concentrations were determined using the HPLC. 
 
The second experiment followed almost the same procedure and had the same 
experimental conditions, but some changes were made in order to improve the 
performance of the experiment. The temperature was increased to 37 °C because it 
was checked that inside the tubes the temperature decreases around 0.5 °C and the 
cells do not grow properly when the temperature is that low.  
 
Furthermore, the working Cv was changed between both experiments. In RMB03.02 
1 MVC/mL was the decided working cell density, thinking that it was high enough to 
be able to see the different behaviour in the metabolism of the cells. But according 
to the results, these changes were not always distinguished so the Cv was increased, 
1.5 MVC/mL, in the second experiment to make them possible to detect.  
 
Taking into account all the previous aspects, the methodology in experiment 2 was 
as follows: 
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Day 1. The cells were inoculated at Cv 0.5 MVC/mL and a volume of 5 mL of medium 
was added. Then the tubes were put in the incubator (37 °C, 200 rpm, 5% CO2). 
 
Day 2. The cells were let to grow to reach the desire Cv, 1.5 MVC/mL, so the culture 
was only centrifuged and 5 mL of fresh medium was added. 
 
Day 3. Same procedure as day 2 in experiment 1. 
 
Day 4. One sample was taken to determine the cell density.  The culture was 
centrifuged and 5 mL of fresh medium was added. 
 
Day 5. Same procedure as day 3 in experiment 2 but using a Cv of 0.8 MVC/mL. In 
some CT only the sample was taken and they were left again in the incubator in 
order to let the cells recover.  
 
Following days. Same procedure as day 3 in experiment 2. 
 
Finally, both experiments had different set of CT. The variation in the amino acids 
must be large enough to produce significant changes between the distinct 
centrifuges tubes, causing the cells to take other pathways in the metabolic reaction 
network. For that reason, in RMB03.02 some amino acids were not added to the 
medium since this was the largest change that could be done. 
 
The different compositions of the amino acids can be seen in Table 4.4. When it says 
100% it means that the whole amount of the amino acid was added and when it says 
0% it means that the amino acid was not added. 
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Table 4.4. AA composition the media for RMB03.02 in % of their concentration in the medium 
RMB03.02 
Components CT1 CT2 CT3 CT6 CT7 CT9 CT12 
Alanine 0 100 100 100 100 100 100 
Asparagine 100 0 100 100 100 100 100 
Aspartate 100 100 0 100 100 100 100 
Cysteine 100 100 100 100 100 100 100 
Glutamate 100 100 100 0 100 100 100 
Glutamine 100 100 100 100 100 100 100 
Glycine 100 100 100 100 0 100 100 
Proline 100 100 100 100 100 100 100 
Serine 100 100 100 100 100 0 100 
Tyrosine 100 100 100 100 100 100 100 
EAA 4 100 100 100 100 100 100 100 
 
The same idea was used to determine the set of centrifuges tubes for Experiment 2. 
But in this case, the effect in the cells of adding only half of the concentration (50%) 
of the amino acids used in RMB03.02 was also studied, bearing in mind that the cells 
need all the essential amino acids in the medium to grow. Thus, the final 
composition of the tubes in that second experiment was: 
 
 
                                                        
4 Arginine, Histidine, Isoleucine, Leucine, Lysine, Methionine, Threonine, Tryptophan and Valine 
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Table 4.5. AA composition the media for RMB03.02 in % of their concentration in the medium 
Experiment 2 
Comp. CT1 CT2 CT3 CT4 CT5 CT6 CT7 CT8 CT9 CT10 CT11 CT12 CT13 CT14 
Ala 0 50 100 100 100 100 100 100 100 100 100 100 100 100 
Asn 100 100 100 100 100 100 100 100 100 100 0 50 100 100 
Asp 100 100 100 100 0 50 100 100 100 100 100 100 100 100 
Cys 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
Glu 100 100 100 100 100 100 0 50 100 100 100 100 100 100 
Gln 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
Gly 100 100 100 100 100 100 100 100 0 50 100 100 100 100 
Pro 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
Ser 100 100 0 50 100 100 100 100 100 100 100 100 100 100 
Trp 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
Tyr 100 100 100 100 100 100 100 100 100 100 100 100 100 100 
Other EAA 5 100 100 100 100 100 100 100 100 100 100 100 100 50 100 
 
                                                        
5 Arginine, Histidine, Isoleucine, Leucine, Lysine, Methionine, Threonine and Valine 
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4.5. HPLC 
 
The instrument used in order to determine the concentration of amino acids was the 
High Pressure Liquid Chromatography (HPLC). The technique followed was the pre-
column derivatization and reversed phase. 
 
The system consisted in 3 Water 510 Pumps, a WISP autoinjector, a column heater 
and one Waters 486 UV-detector. Three elution buffers were used, one for each 
pump. Eluent A was obtained with 100 mM NaAc and 5.6 mM Triethylamine and 
followed by adjusting the pH to 5.7 using 50% phosphoric acid. Eluent B was 
obtained with 100 mM NaAc and 5.6 mM Triethylamine and followed by adjusting 
the pH to 6.8 using 50% phosphoric acid. Eluent C consisted in MeCN at 100%. 
 
The derivatization of the amino acids was carried out using Waters AccQ-Fluor 
reagent 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AQC) and they were 
detected using a UV detector at 254 nm and separated on a C18 column. 
 
In this study the proteins and peptides were not object to study. For that reason, the 
samples were precipitated before they were analyzed in the HPLC to avoid the 
interference of these components in the chromatogram.  The TCA precipitation 
protocol designed by [45] was used and it is as follows: 
 
 TCA was added to the samples in order to reach after precipitation a TCA 
concentration of 0.03M.  
 The samples were after incubated at room temperature during 20 min. 
 The samples were centrifuged at 13K rpm during 10 min. Following, the 
supernatant was diluted a factor D and the pellet was discarded. 
 
Once the samples were precipitated, they were mixing with AccQ·Fluor Borate 
Buffer and AccQ·Fluor Reagent. An internal standard, -aminobutyric acid (AABA) 
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was added to the samples mixture, which helped in the quantification of the 
different peaks of the chromatogram.  
  
The calculation of the concentration of the amino acids were made using the areas of 
the different peaks of the chromatogram, as follows: 
 
Caa D Cst
Asa Ist
Ast Isa
                                                         (28) 
 
where  
 Caa is the concentration of amino acid in sample 
 D is the dilution factor (if applicable)  
 Cst is the concentration of amino acid in standard 
 Asa is the area of amino acid in sample 
 Iist is the area of internal standard in standard 
 Ast is the area of amino acid in standard 
 Isa is the area of internal standard in sample 
 
As it can be seen, a standard is required to determine the concentration of the amino 
acids. In this case, the standard had a concentration of each amino acid of 100 M.  
 
4.6. Modelling 
 
The modelling was performed using the software Matlab (MathWorks, Version 7.9). 
The Metatool was used as it was explained in the introduction part. The modelling 
methodology was described in the Introduction6. A user-friendly modelling tool was 
developed. 
                                                        
6 Notice however that in RMB03.02 Eq. 4 was used to calculate the qi while in Experiment 2 Eq. 6 was 
used more appropriately since a pseudo-perfussin is applied and 
dC
dt
0  
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5. RESULTS  
 
5.1. Experiment 2 
 
The experiment was carried out to obtain data to be used in the mathematical 
model. The culture was done varying the aa concentration in the medium in the 
different tubes in order to trigger different metabolic pathways.  
 
At the beginning, 1.5 MVC/mL was thought to be the working Cv.  However, between 
day 2 and 4 there were a lack of CO2, affecting the well growth of the cells. After this 
unexpected setback, the Cv was changed to 0.8 MVC/mL in order to have the same 
conditions in the following days of the experiment. 
 
The cells started to resume after the problem with CO2. The recovery was already 
seen in the fifth day of the culture. Nevertheless, this effect was not visible in all the 
tubes and for that reason the medium was not renewal in these CT’s. The tubes 
affected were CT2, CT4, CT8, CT9, CT11 and CT13. Fortunately, the main methodology 
of these tubes could be continued again after that day. 
 
The seventh day showed that, even the previous day they seemed that they were 
getting better, CT9 and CT13 did not recover at all, maintaining a very low Viability 
and not growing. Accordingly, it was decided not to continue with them after this 
day. 
 
In this case, not all the samples were analyzed in the HPLC because it was known, 
from previous experience, that some data would not be able to be used by the 
simulation program. Therefore, a selection of samples was made taking two aspects 
as requirements. The first one was that the cells grew from the previous day and the 
second one that the viability was above a reasonable threshold. It was decided that 
when the cells had a Viability above 75% was reasonable to be analyzed by HPLC. 
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Therefore, taking into account the two previous requirements, the selection of 
samples was the following one: 
 
Table 5.1. Decision of the days to make the AAA 
 D1 D2 D3 D4 D5 D6 D7 D8 D9     
CT1 NA NA NA NA NA A A A      
CT2 NA NA NA NA NA A A A A     
CT3 NA NA NA NA NA A A A A     
CT4 NA NA NA NA NA A A A      
CT5 NA NA NA NA A A A A    NA Not-anal. 
CT6 NA NA NA A A A A A      
CT7 NA NA NA NA A A A A      
CT8 NA NA NA NA NA A A A A     
CT9 NA NA NA NA NA NA NA     A Analyzed 
CT10 NA NA NA NA A A A A      
CT11 NA NA NA NA A A A A      
CT12 NA NA NA NA NA NA A A A     
CT13 NA NA NA NA NA NA NA       
CT14 NA NA NA A A A A A A     
 
 
The problems that there were during the AAA of RMB03.02, where different peaks 
of aa were eluated together, disappeared in this AAA. In this case, and after two runs 
of the samples, all the concentrations of all the aa were obtained. However, other 
problems arose. 
 
Once the qi were calculated, it was noticeable, as in RMB03.02, that the 
concentrations of some eaa were higher than the concentration of them in fresh 
medium. This is not feasible since the cells could not produce an eaa. 
 
Another important aspect that must be mentioned is that it seemed that the analysis 
of some aa was altere when the samples of spent media were frozen for store and 
defrozen to be analyzed. This was, for example, the case of Gln and the values could 
be compared with the values of the Bioprofile. It can be said that some values of Gln 
in the HPLC were not reliable, giving very high values comparing with the same 
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value in Bioprofile. For that reason, the concentration of Gln obtained in the 
Bioprofile was used. Other example was NH4 and the same solution was taken.  
 
All of these dilemmas led to think that the AAA done by the HPLC was not totally 
trustable and this problem is discussed a little bit further in the discussion section. 
 
Despites the problems encountered with the AAA, several days that could be used in 
the simulation program. In total, twelve samples fulfilled the condition that an eaa is 
consumed in the system (CTiDj: ”sample of centrifuges tube i of day j”): 
 
 CT1D06 and CT1D07: no Ala was added to the medium. 
 CT2D09: half of the original concentration of Ala was added to the medium. 
 CT4D06: half of the original concentration of Ser was added to the medium. 
 CT5D06, CT5D07 and CT5D08: no Asp was added to the medium. 
 CT6D06, CT6D07 and CT6D08: half of the original concentration of Asp was 
added to the medium. 
 CT10D05 and CT10D08: half of the original concentration of Gly was added to 
the medium. 
 
All the data and calculations of Experiment 2 can be found in Appendix D. 
 
5.2. Simulation results of Experiment 2 
 
 
The model was applied using the stoichiometric matrix that can be found in 
Appendix A and the samples above mentioned. The model determined that the 
system had 143 EFM.  
 
A first aspect that can be mentioned is that the inequation in Eq. 24 that must be 
fulfilled in order to get the optimal solution when applying the non-negative least-
square was accomplished: 
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p NS 25 12 300 N 143 
 
In Tables 5.2 and 5.3 the obtained reduced system are presented. Only the reactions 
of the macroscopic system that have the maximal kinetic rate above zero are 
presented. 
 
Table 5.2. Maximal kinetic rates of the reduced model 
1 2 3 4 5 6 7 8 9 
477.664 2703.740 130.400 63.384 158.107 854.224 55.522 391.418 549.279 
10 11 12 13 14 15 16 17 18 
477.664 2703.740 130.400 63.384 158.107 854.224 55.522 391.418 549.279 
19 20 21 22 23 24 25 26 27 
29.200 1182.876 406.646 183.080 291.968 17.192 148.692 661.105 286.323 
28 29 30 31 32     
249.944 105.417 53.959 1704.1 157.198     
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Table 5.3. Reduced stoichiometric matrix of the macroscopic system 
 R1 R2 R3 R4 R5 R6 R7 R8 R9 R10 R11 R12 R13 R14 R15 R16 R17 R18 R19 R20 R21 R22 R23 R24 R25 R26 R27 R28 R29 R30 R31 R32 
Glc 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 -0.5 -0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.0208 0 
Lac -1 2 3 1 1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Gln -1 0 0 1 0 -1 -2 0.5 0 0 1 0 0 0 0 0 -1.5 -1 -1 1 1 1 1 0 0 1 0 0 1 0 0 0 
NH4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 -1 -0.0377 0 
Asp 1 0 2 0 0 0 0 1 0 -1 0 1 0 0 -1 0 1 1 1 0 -1 0 0 0 0 1 1 1 1 1 -0.0006 0 
Glu 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 -0.007 0 
Ser 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 -0.0033 0 
Asn 0 0 -1 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.0084 0 
Gly 0 0 0 0 0 0 0 0 -0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.0133 0 
His 0 0 0 -1 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.0101 0 
Thr 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 -0.0033 0 
Arg 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 -0.0055 0 
Ala -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.008 0 
Pro 0 0 0 0 0 0 0 -0.5 0 0 0 0 0 0 0 0 -0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.004 0 
Tyr 0 0 0 0 -1 0 0 0 0 0 0 0 0 -1 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 -0.0096 0 
Cys 0 0 -1 0 -1 1 0 0.5 0 1 0 0 0 0 0 0 1.5 0 0 -1 0 0 0 0 0 0 0 0 0 0 -0.0133 0 
Val 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
Met 0 0 0 0 1 0 2 -1 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 -0.026 0 
Iso 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 -1 0 0 1 0 0 0 0 0 0 0 0 -0.0004 0 
Leu 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 -1 0 0 0 0 0 0 -0.0165 0 
Lys 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 -0.0081 0 
Phe -1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 -1 0 1 0 0 0 0 0 0 -0.0099 0 
Tryp 0 0 -1 0 0 0 -1 0 0 0 0 0 -1 0 0 0 -1 -0.5 0 0 0 0 0 0 1 0 0 0 0 0 -0.0077 0 
Biomass 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 -1 
Death 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 
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The next figures compare the experimental data specific consumption/production 
rates qexp, (blue line) using Eq. 8 and the estimated ones by the reduced model qest 
(red line) using Eq. 23. Each plot represents one day of one CT. The 
consumption/production rates of all the metabolites are represented by one data 
point each. The metabolites are given in X-axis and each one is associated with a 
number listed in Table 5.4. 
 
Table 5.4. Number of the metabolites 
1. Glc 14. Thr 
2. Lac 15. Trp 
3. NH4 16. Val 
4. Gln 17. Ala 
5. Biomass 18. Asn 
6. Glu 19. Asp 
7. Arg 20. Cys 
8. His 21. Gly 
9. Ile 22. Pro 
10. Leu 23. Ser 
11. Lys 24. Tyr 
12. Met 25. Cell death 
13. Phe   
 
 
Normally, the first four external metabolites of the system (Glc, Lac, NH4 and Gln) 
and also the biomass have a much higher specific consumption/production rates 
than the rest. Therefore, it was decided to plot them separately from the other 
external metabolites. In this manner it was easier to evaluate the performance of the 
model. 
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Figure 5.1. Comparison between qexp  (Eq. 8) and qest (Eq. 23) for Glc, Lac, NH4, Gln and Biomass 
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Figure 5.2. Comparison between qexp (Eq. 8) and qest (Eq. 23) for the other external metabolites 
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These plots gave a qualitative point of view. In order to quantify, the average error 
of each metabolite between both rates was calculated: 
 
Table 5.5. Average error between qexp (Eq. 8) and qext (Eq. 23) for all the external metabolites (%) 
Glc Lac NH4 Gln Glu Arg His Ile Leu Lys 
78 20.4 13.8 46.8 57.4 178.8 71.7 37.7 30.2 64 
Met Phe Thr Trp Val Ala Asn Asp Cys Gly 
50.4 77 71.1 96 32.2 16.4 153.4 541.3 45.6 23.9 
Pro Ser Tyr Biomass Cell death    
30 81.3 41 14.5 151.3    
 
 
It can be seen that in general the error between the estimated value and the 
experimental value is not very high. However, there are 4 metabolites that had a 
highly unexpected error.  They appear in red in Table 5.5 and they are Asn, Asp, cell 
death and Arg. It was difficult to explain this phenomenon and in a first approach, it 
could be said that something did not work well in the model for these components. 
For that reason, the error in each sample was studied. Tables 5.6.a and 5.6.b show 
these errors. 
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Table 5.6.a. Error between qexp (Eq. 8) and qest (Eq. 23) in each sample and metabolite (%) 
 CT1D06 CT1D07 CT2D09 CT12D06 CT5D06 CT5D07 
Glc 39.10 6.71 -677.43 20.27 -0.27 4.45 
Lac 7.30 11.11 20.77 -34.36 -22.36 -19.65 
NH4 8.45 -10.69 2.80 24.14 -14.13 2.26 
Gln 74.09 30.07 32.64 82.50 64.82 28.54 
Glu -103.56 14.39 61.28 -28.27 -148.68 42.36 
Arg 32.08 31.59 -826.23 59.91 32.63 -221.08 
His -17.95 16.96 -365.73 60.48 17.12 -69.20 
Ile 14.12 -1.12 -111.73 54.34 24.97 -75.69 
Leu 16.34 -8.85 -69.55 43.16 5.17 -75.23 
Lys 28.95 2.04 -310.24 55.88 9.65 -91.75 
Met -46.49 -30.94 3.15 58.30 20.81 -51.44 
Phe -17.03 -23.15 -390.51 9.84 66.57 -66.63 
Thr 14.88 9.41 -211.21 64.10 6.97 -185.88 
Trp -305.00 -105.61 -33.44 -191.46 40.89 45.47 
Val 5.79 0.61 -63.49 50.08 -16.81 -81.30 
Ala 8.97 -10.17 10.54 -59.65 -48.47 2.48 
Asn -56.67 -77.63 71.95 68.56 239.96 69.94 
Asp -57.90 94.74 -56.65 70.08 56.44 45.85 
Cys -47.29 -52.21 -95.94 21.29 62.36 -35.90 
Gly -16.13 -12.62 -42.59 52.02 1.55 -31.88 
Pro -23.02 3.04 -25.92 42.53 13.85 -47.40 
Ser 250.52 -145.74 -24.69 73.63 -50.07 -65.99 
Tyr 4.29 -32.05 -69.81 40.18 15.34 -124.24 
Biomass 4.87 -19.40 -19.27 -9.81 -20.23 -23.93 
Cell_death -20.88 97.59 96.34 23.17 97.11 96.05 
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Table 5.6.b. Error between qexp (Eq. 8) and qest (Eq. 23) in each sample and metabolite (%) 
 CT5D08 CT6D06 CT6D07 CT6D08 CT10D05 CT10D08 
Glc -139.21 17.83 17.62 6.41 -5.32 -0.79 
Lac -35.13 25.18 3.92 21.32 -37.25 5.60 
NH4 -10.86 -53.24 -5.90 -12.01 -19.48 -2.91 
Gln 28.99 61.31 36.22 34.53 71.03 21.60 
Glu 24.56 -41.73 -44.17 -83.38 37.31 58.48 
Arg -802.15 33.07 -32.99 -4.83 -20.20 48.46 
His -183.08 29.45 -16.08 -20.75 -17.70 45.66 
Ile -64.42 24.08 -21.13 10.15 -10.94 39.36 
Leu -61.26 10.07 -26.70 -6.95 12.04 26.84 
Lys -107.21 23.36 -42.82 -23.07 -33.62 39.21 
Met -162.44 21.29 -10.68 50.90 -93.35 55.26 
Phe -101.88 47.74 -71.00 56.48 -40.90 32.25 
Thr -191.43 14.13 -66.67 -16.53 -34.13 37.47 
Trp 55.00 60.67 -35.44 63.26 -213.22 -2.03 
Val -60.59 16.88 -15.26 6.97 -23.10 45.64 
Ala -3.00 -2.09 18.34 6.97 6.79 -19.77 
Asn 72.84 211.42 70.38 59.89 122.72 719.28 
Asp -22.39 -101.91 52.96 25.92 -258.49 -5665.12 
Cys -36.38 58.48 -11.43 38.86 -54.84 31.88 
Gly -23.47 14.42 -10.26 -5.12 -29.70 47.08 
Pro -39.00 42.73 -8.97 12.92 -59.10 42.18 
Ser -68.07 -126.78 -8.07 -107.42 44.54 10.00 
Tyr -60.19 24.18 -47.35 11.82 -5.75 56.66 
Biomass -19.75 -11.40 -13.55 -13.87 -6.89 -17.90 
Cell_death 95.28 86.25 72.28 75.12 -14.62 94.73 
 
Finally the average error was recalculated using the values that had an error below 
100% and they are presented in Table 5.7: 
 
Table 5.7. Average error between qexp (Eq. 8) and qest  (Eq. 23) with the error below 100% (%) 
Glc Lac NH4 Gln Glu Arg His Ile Leu Lys 
11.9 20.3 47.2 43.6 32.9 32.9 31.1 30.1 30.2 35.1 
Met Phe Thr Trp Val Ala Asn Asp Cys Gly 
40.2 43.2 29.4 42 32.2 16.4 68.5 53.7 45.6 24 
Pro Ser Tyr Biomass Cell death    
30.1 58 41 14.5 151.3    
 
 
The difference between the estimated values (red line) and the experimental values 
(blue line) could also be studied using Fig. 5.3, where each plot corresponds to one 
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metabolite and each plot had all the samples, i.e CT1D06, CT1D07…, order from 1 to 
12 in the same order as they were presented before: 
Figure 5.3.a. Comparison between qexp (Eq. 8) and qest (Eq. 23) divided in samples 
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Figure 5.3.b. Comparison between qexp (Eq. 8) and qest (Eq. 23) divided in samples 
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Figure 5.3.c. Comparison between qexp (Eq. 8) and qest (Eq. 23) divided in samples 
 
5.3. Evolution over time prediction 
 
In order to study the quality of the model, a simulation of the concentration in time 
was done. The main idea of this simulation was to perform one CT culture during 
one day in time intervals of 0.2 days using Eq. 28. It was decided to take CT1 and it 
was simulated from day 6 to day 7. Fig. 5.4 shows the estimated concentrations of 
the different metabolites (red line) and the experimental data for all the external 
metabolites (blue line): 
Figure 5.4.a. Time evolution of the concentration of the metabolites from day 6 to 7 in CT1 (Eq.31) 
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 Figure 5.4.b. Time evolution of the concentration of the metabolites from day 6 to 7 in CT1 (Eq.31) 
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Figure 5.5.c. Time evolution of the concentration of the metabolites from day 6 to 7 in CT1 (Eq.31) 
 
5.4. Simplified systems 
 
Since the cells cannot synthetize the eaa, these aas are used scarcely by the cells. 
Consequently, the uptakes of all the eaa are usually very well correlated with each 
other. In other words, in term of modelling, they bring the same information. 
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This property was exploited in order to use more experimental data. As a matter of 
fact some of the experimental data were not used in the complete system since the 
eaa consumption/production rates were negative. It was tested to discard some eaa. 
 
As a result, it was decided to simplify the model discarding some eaa and be able to 
use more samples as input parameters. The possibility to use samples of the tubes 
that were not used in the complete system was the criteria followed to determine 
these new simplified systems.  
 
Two simplified systems were created and two eaa were discarded in each system: 
 
 Simplified system 1: Trp and Lys were discarded.  
 Simplified system 2: Trp and Phe were discarded. 
 
Both systems used the same samples as the complete system as well as other 
samples that fulfilled the eaa requirement for the eaa that were still in the system: 
 
 Simplified system 1: CT3D07, CT6D04, CT10D06 and CT10D07 
 Simplified system 2: CT7D08, CT8D09, CT10D06, CT10D07, CT11D09 and 
CT12D08. 
 
Table 5.8 and 5.9 show the average error of all the metabolites present in the 
simplified system 1 and the simplified system 2: 
 
Table 5. 8. Average error between qexp (Eq. 8) and qest (Eq. 23) for the external metabolites in the 
first simplified system (%) 
Glc Lac NH4 Gln Glu Arg His Ile Leu Met 
96 19.8 27.6 66.5 91.9 174.0 86.3 39,6 35,3 47,8 
Phe Thr Val Ala Asn Asp Cys Gly Pro Ser 
121.1 80.0 41.5 16.7 108.1 607.8 44.4 52,7 33,5 97,2 
Tyr Biomass Cell death     
47.6 18.5 124     
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Table 5.9. Average error between qexp (Eq. 8) and qest (Eq. 23) for the external metabolites in the 
second simplified system (%) 
Glc Lac NH4 Gln Glu Arg His Ile Leu Lys 
80.3 18.4 13.2 44.4 66.7 219.4 237.0 44,0 33,7 57,9 
Met Thr Val Ala Asn Asp Cys Gly Pro Ser 
59.3 97.2 34.0 21.4 140.7 248.9 41.9 36,0 22,6 161,9 
Tyr Biomass Cell death     
40.9 21.9 118     
 
5.5. Graphical interface 
 
A mathematical model that gives the prediction of the evolution of the medium 
compound was studied in this project. The main objectives was to test the model 
using different experimental data and check its validity, 
 
The model, which was implemented by Joan Gonzalez [40], was done using Matlab 
as a programming language. Since previous knowledge of Matlab was required to 
use it, a Window application was done during the realization of this project. The 
main purpose of this Window application was to facilitate the user its manipulation, 
without the need for programming skills.  
 
The former modelling method was divided in two main parts. The first part, called 
Method Tools, performed the calculation of the model itself. The second part used 
the parameters calculated by Method Tools to predict the consumption/production 
rates qi and represent them graphically. Both parts used the methodology that was 
presented in section 2.5. 
 
The Window application is a very easy tool that has the same functionality that the 
former modelling method. Some functions were changed to make the code simpler 
and more understandable. New functions were also added in order to have more 
tools to evaluate the behaviour of the system object to study and the validation of 
the model selected. 
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When the user opens the program, the user will find a window like the following 
one: 
 
Figure 5.6. Graphic interface 
 
The main menu that appears in the upper part of the window is divided in 4 
submenus: 
 
 Method Tools 
 Result Tools 
 Network  
 Help 
 
5.5.1. Method Tools 
 
This submenu, which is the responsible of the creation of the model, has different 
tabs.  
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Clicking in ‘See system’, a small drop-down menu appears in the upper left corner 
and the user can choose the input parameter to be see, which are necessary for the 
program to determine the model: 
 
 Aint: stoichiometric matrix of the external metabolites. 
 Aext: stoichiometric matrix of the external metabolites. 
 Irreversibility: a vector with length equal to the number of reactions, where 
each element indicates if the reaction is reversible with a 1 or if it is not with a 0. 
 Michaelis constant: a vector with length equal to the number of external 
metabolites, where each element indicates the Michaelis constant of each 
external metabolite. 
 Concentrations: matrix where each element Ci,j contains the concentration of 
the metabolite i of the sample j. 
 Q: matrix where each element Qi,j contains the consumption/production rate of 
the metabolite i of the sample j. 
 
It is also possible to introduce a new system clicking in ‘New system configuration’. 
The program is made so that the user only can enter the parameters in a 
predetermined order, without being able to enter the next until the user has 
introduced the preceding ones. The order is the same as the above description of the 
parameters. 
 
The parameters have to be introduced directly, typing all the values. It is necessary 
to introduce some values before defined matrices can be created.  These values are 
the number of reactions and number of samples, as well as the number of internal 
and external metabolites. The user has to introduce them when the program 
requires them. An example can be when the user has to introduce the stoichiometric 
matrix of the internal metabolites (Aint), the number of reactions and the number of 
internal reactions. In the case of Aint and Aext it is also necessary to introduce the 
name of the metabolites, in order to establish the order in the stoichiometric matrix. 
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If they are not introduced the matrix will not be accepted as valid and the user will 
not be capable to go on in the introduction of the input parameters. The same 
happens in the introduction of the concentrations, where the sample names have to 
be inserted. 
 
Each time that a parameter is well introduced, the corresponding button colour 
turns green.  
 
Finally, the new system can be saved, clicking in ‘Save new system’. The user has to 
enter the path where the system will be saved and each parameter will be saved as 
an Excel file. They are also saved as .mat, the Matlab format. Thanks to that, they can 
be used in the future using Matlab. 
 
The last tab of this submenu is called ‘Find model’ and clicking on it, the model is 
calculated, introducing first the system that is object to study. The program uses the 
function called ‘findmodel’ from [40] to calculate the model, using Eq. 23. The output 
parameters of the model can be seen, selecting them in the drop-down menu that 
appears in the upper left corner. A button called ‘Save’ appears at the bottom of the 
window and when clicking on it, the model is saved. The model is saved in the same 
formats as explained above. 
 
The model consists of: 
 
 Amac: stoichiometric matrix of the macroscopic reactions, which corresponds to 
all the elementary flux modes. 
 Maximum rate: vector of length equal to the number of reactions, whose 
elements express the maximal kinetic rate in which the reaction can be 
produced. 
 Elementary modes: matrix that contains all the elementary flux modes. 
 Number of elementary modes 
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 External reactions: vector that indicates the reactions that only involve 
external metabolites. 
 Ared: the same as Amac but for the reduced model. 
 MUred: the same as maximum rate but for the reduced model. 
 Error:  error produced when the non-negative least-squares equation is used to 
determine the maximum rate. 
 
5.5.2. Result Tools 
 
Until the model is calculated, this submenu button remains unable. Once the model 
is established, the user will be able to interact with this submenu. In it, the user can 
predict the consumption/production rates and plot the results in very different 
ways. 
 
The first tab is called ‘Prediction of Q’ calculates the consumption/production rates 
Once the user click on ‘Prediction of Q’, the program shows the estimated qi in a 
matrix where each column corresponds to one sample and each row to one 
metabolite. 
 
After the prediction of the consumption/production rates, the other tabs become 
enable to be utilized by the user. All of them plot the same but in different forms: 
 
 Plot Q’s samples: each subplot corresponds to one sample and represents the 
consumption/production rate of all the metabolites for that sample ordered in 
the same way as in the stoichiometric matrix. 
 Plot errors: calculate the error between the consumption/production rates 
calculated from the experimental data qexp and the estimated  ones qest. Each 
subplot corresponds to a sample. The error is computed using the following 
formula: 
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error
qexp qest
qaverage
                                                         (29) 
 
where qaverage is the average of the qexp of the corresponding amino acid in all the 
samples. 
 Plot absolute errors: compute the error between the same parameters as plot 
errors but in another way: 
 
Absolute error
qexp qest
qexp
                                                     (30) 
 
 Plot Q’s metabolites: each subplot corresponds to one metabolite and 
represents the consumption/production rate of all the samples. 
 
In all the cases, the plots are showed in subplots and each figure has at most six 
subplots. The data from the experiment is presented in blue and all the calculated 
data in red.  At the same time, the values appear in the main window.  The different 
figures are not saved directly by the program, but the user has to do it by itself. 
 
The last tab predicts the evolution in time of the concentration of the different 
metabolites using the reduced model. It is necessary to introduce some parameters 
before the program could do the prediction:  
 
 Co: vector that contains the initial concentration of the metabolites.  
 Step time:  time increase between two prediction metabolite concentrations. 
 Time of the simulation: duration of the simulation of the concentration of the 
different metabolites in days. 
 
And the predictions are done using the following formula: 
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kvkikiki Xtqcc ,,,1,                                                      (31) 
 
where t is the step time and Xv,k is the cell density of the system multiplied by 1000. 
 
5.5.3. Network  
 
This tab helps the user to find a metabolite in a system. The user has only to enter 
the name of the metabolite and the program will show in which reaction it appears, 
separating it in substrates and products. 
 
5.5.4. Help 
 
Clicking in this submenu, a manual will appear where the user can find a brief 
description of how the program works. 
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6. DISCUSSION 
 
6.1. Simulation results Experiment 2 
 
Looking at Fig. 5.1 and 5.2, it can be said that the results are promising since in 
general the estimated values and the experimental values are very similar or at least 
they have the same tendency. For example, in CT1D06 and CT1D07 the difference 
between both rates is practically zero for all the metabolites. But, on the other hand, 
there are some samples such as CT2D09 and CT5D08 where there are some 
differences between rates. 
 
As it was said at the beginning, it was thought that the model could not estimate 
Asn, Asp and Arg correctly since the average error that could be seen in Table 5.5 for 
these three metabolites were higher than 100%. Nevertheless, when the error was 
studied separately from all the samples in Table 5.6, it could be seen that this 
unexpected error did not occur in all the samples.  Moreover, the average error is 
sometimes extremely high due to only one or two samples, when in the rest the 
error could be acceptable. 
 
CT2D09 and CT5D08 were the samples that had more errors above 100%. It could 
be seen that the error of some metabolites only occurred in these two samples.  
These are the cases of Glc, His, Ile, Lys, Met and Phe. It was seen that the 
experimental rates of most of these metabolites diverge from the rest of the rates 
for the same CT, being much lower. Furthermore, the rates obtained by the model 
are more likely to the experimental rates of the other samples than the obtained 
during the AAA. For all these reasons, it seems reasonable to say that some 
problems arose in the measurement of these metabolites. 
 
Other two metabolites that had a considerable high error in CT5D08 compared to 
the other samples are Arg and Thr. However, these two metabolites had also a high 
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error in CT5D07. This may lead to think that when the Asp concentration in the 
medium is varied, the cell metabolism takes other pathways that affect the Arg and 
Thr concentration and the model is not capable to detect them. Nevertheless, these 
errors are not present in the samples of CT6 where the concentration of Asp in the 
medium was also modified.  Therefore, it is likely to think that this error is caused 
by other reason. This reason could be the same as explained before, the bad 
measurement of the concentration of these metabolites. 
 
Besides CT2D09 and CT5D08, there are only a few cases more where the error is 
above 100%. They seem to be random errors that could occur as a consequence of a 
bad measurement of the concentrations or to some reactions that are not explained 
in the model. But, to be able to affirm the second hypothesis more simulations must 
be done using other set of experimental data. Unfortunately, this is not yet available. 
 
According to all this explanation, it is reasonable to say that the errors above 100% 
are due to problems in the measurements. For that reason, the error was 
recalculated using only the errors that were below 100%. This did not affect the cell 
death.  
 
The results of the new average exposed in Table 5.7 showed that the error 
diminished for all the samples considerably and in most of the metabolites this error 
is below 50% which can be consider a well performance of the model. Only four 
metabolites had an error above 50%: cell death, Asn, Asp and Ser. 
 
According to the results obtained using the average error and Fig. 5.3, there are 
several aspects that can be mentioned: 
 
 The rate of the biomass is almost all the time very flat; meaning that it does not 
change too much in the different CT and this is well estimated by the model. The 
only problem is that the estimated rates of the biomass are always higher than 
the experimental rates. This could mean that the simplified version of the 
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biomass reaction works well, but there is something that this reaction could not 
explain and it happens in the culture of CHO cells. 
 
 The same happens with Gln since the estimated specific 
consumption/production rates are always higher than the experimental values. 
The system may lack some reactions to explain this phenomenon. 
 
 Asn rate estimation is one the worse ones and this can be observed in the plot of 
Asn.  The experimental values and the estimated rates diverged in almost all the 
cases. It means that there are again some effects in the metabolism of the CHO 
cells that the simplified model cannot explain. 
 
 Even though Asp and Ser have a slightly high error, the tendency that the 
estimated rates followed is the same as for the experimental rates. 
 
 The cell death was a new metabolite added during the realization of the present 
Thesis and it was added using a very simple reaction that relates the cell viability 
with it. Unfortunately, the error and Fig. 6.4 show that there are other aspects 
that affect the cell death. On the other hand, the system was done without this 
reaction and the results were very similar. 
 
The trigger of different metabolic pathways in the cell metabolism was 
accomplished since different consumption/production rates of each metabolite 
were obtained for the different samples, as it is showed in Fig. 5.3. The capability of 
the system to detect these changes can be also studied, observing the same figure. 
The specific consumption/production rate of each eaa should be constant. This is 
due to the fact that the rates of the eaa depend only on the cell density of the cells 
and the rates are divided by it, making them constant. This can be seen in Fig. 5.3 for 
the estimated rates of the eaa, such as Arg and His, but this does not happen in the 
 67 
experimental values because of the imprecision of the methodology used to 
calculate them.  
 
In the case of the non-essential aa, the estimated rates are different in different 
samples and in general the metabolites followed the same trend as the experimental 
rates. Good examples are Gly and Ala. According to that, it can be said that the 
system can detect the trigger of the metabolic pathways for the non-essential aa. 
Unfortunately, this does not happen in the case of Glc, Lac and NH4 where the 
corresponding estimated rates remain almost constant for all the samples. This 
could mean that some reaction are missing in the system that involve these three 
metabolites or that the system requires more changes in the initial conditions to be 
able to trigger different pathways for that metabolites. 
 
6.2.  Evolution over time 
 
The results shown in Fig.5.4 are very satisfactory since in almost all the cases the 
simulated values and the experimental values are equal or very similar. The errors 
of the concentrations after one day are in the range of 10-20% for almost all the 
metabolites. Moreover, the tendency in all the metabolites is the correct one. The 
products increase their concentration and the substrates decrease their 
concentration. Only for Trp and the Biomass the error is around 40%. Concerning 
these, three aspects can be mentioned. 
 
The first one is the Biomass. The simulated Biomass concentration is so much higher 
than the experimental one. The cells grew from day 6 to day 7 but not as in theory, 
where the cells grow twice every day. This could be an explanation of why the 
Biomass differs from the simulated value. 
 
The other two aspects involve the concentration evolution over time of Trp and Ser. 
In the case of Trp. it was shown that the simulated value in CT1D07 and the 
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experimental value were very different. This may be due to an error of the 
measurement of its concentration. Trp peak is a very small peak in the 
chromatogram in the HPLC.  
 
Finally, Ser shows a difference between the simulated rate and the experimental 
value. This, in addition of what was explain before can mean that there is some lack 
of information in the system that describes the metabolism of Ser. 
 
6.3. Simplified systems 
 
It can be seen from the results obtained in Table 5.8 and 5.9 that both simplified 
systems had very similar results to the complete system. This shows that some 
simplifications can be done and the well performance of the model remains.  It could 
be said, that the results could be more reliable since more data were used in the 
simplified systems.   
 
In the simplified system 2, the His error is very high but it is the same problem 
observed in the complete system with some metabolites. So, this could also be 
explained as an error in the measurements of the His concentration. 
 
One important aspect to mention is the case of Ser that was discussed in the 
previous analysis. In this case, it could be seen that in both cases the error is higher 
than in the complete system. Since more data is used in these two methods, it is very 
likely to say that the network does not describe well the metabolic pathways that 
Ser follows in the cells metabolism, meaning that some reactions are missing in the 
system that involve Ser. This aspect should be important to study in the future when 
more data will be available. 
 
In general, the order of magnitude of the error for the rest of the metabolites is the 
same but there are cases, where the error diminishes. Examples can be Ala and NH4. 
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This gives consistency to the method and shows that the network is, for some 
metabolites, well defined.  
 
6.4. HPLC problems 
 
During the AAA in RMB03.02, it was thought that the fact that the cells did not grow 
at all could explain all the problems encountered in the eaa. But, as it was said 
before, these problems did not disappear in Experiment 2 where the cells grew 
satisfactorily.    
 
Another important aspect that was observable during the AAA, was the difference 
obtained between the same sample in different runs. It could be reasonable to 
accept that the error obtained from this difference is below 15-20% since the 
conditions (temperature. buffers…) from one run to another may differ. On the other 
hand, in small peaks, and consequently small concentrations, high errors could be 
also accepted. But in some cases the difference were higher that this acceptable 
threshold. Diverse hypothesis were thought to explain this phenomenon. 
 
The most likely could be that the precipitation protocol followed with TCA in order 
to avoid the interferences of proteins and peptides in the AAA did not work 
properly. One or several non-desired components, which are still unknown, could be 
eluated together with some aa. This would explain why the concentrations of some 
eaa’s are higher than the concentration of them in fresh media. 
 
This did not happen in the case of fresh medium since these undesired components 
are not present. Looking at the different runs of the fresh media, the error obtained 
is, in general, smaller than in the cases of a sample of media that was in contact with 
cells. 
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As a consequence of this, some tests are going to be performed in order to check the 
good performance of the protocol. The main idea is to take one sample with a low 
Viability, which have a lot of accumulated proteins, and apply different 
concentration of TCA and time to incubate the sample after precipitation to check 
the reliability of the method. 
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7. CONCLUSIONS 
 
The model used in this Thesis was checked and corrected when it was necessary. 
But after these corrections, the model can be considered a highly satisfying model 
under a theoretical point of view. A graphical interface was done to facilitate the 
user use without the necessity of programming skills. 
 
It is difficult to determine the performance of a dynamical model when there is only 
available one set of data under some defined conditions. A lot of hypothesis can be 
done using the results obtained but they cannot be tested. In this Thesis the model 
and the metabolic reaction network used to the modelling succeed in the estimation 
of the system behaviour under the conditions of changing one aa in the composition 
of the medium. 
 
In general, the error between the real rates and the estimated rates are small. Only 
four metabolites have an error above 50%: cell death, Asn, Asp and Ser. It can be 
said that some reactions are missing in the system that involve these metabolites.  
 
Although the error is not very significant, it was also observable that some reactions 
that describe the metabolism of Gln and the biomass are missing since the rates of 
the estimated values are always above the real rates. 
 
The system can follow the difference metabolic pathways that the cells take when 
one aa in the composition of the media is varied. Only the rates of Glc, Lac and NH4 
are not affected by the changes in the initial conditions of the culture, which is a 
drawback of the system. 
 
The model also succeeded in the simulation over time of the concentration of the 
extracellular metabolites. Except Ser and biomass, the errors between the simulated 
concentration and the real concentrations are below 20%. 
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Finally, it was observed that it is possible to omit some eaa’s in the system without 
deteriorating the modelling quality. 
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8. FUTURE WORK 
 
 
This Thesis was only a start point of the amount of work that must be done in order 
to validate the model. In the realization of this project, the experiments were carried 
out changing only the composition of one element in the media, aa. Nevertheless, 
there are several other experiments that can be done. 
 
According to that, the main work in the future has to be focused in the obtaining of 
new experimental data under different environmental conditions. These 
experiments can involve changes in the temperature and the study of the effect of 
the glutamine in cell culture. It can also be varied more than one aa in the culture 
media.  This data will helped to determine even better than in this project the good 
performance of the model. 
 
Another important task will be the improvement of the methodology followed in the 
analysis of the samples since it was seen that some modelling errors were caused by 
measurements with a high analysis error of the extracellular metabolites.  
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APPENDIX A: Metabolic reaction network 
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Table A.1. Stoichiometric matrix of a CHO system 
  R1 R2 R3 R4 R5 R6 R7 R8 R9 R10 R11 R12 R13 R14 R15 R16 R17 R18 R19 R20 R21 R22 R23 R24 R25 R26 R27 R18 R29 R30 R31 R32 R33 R34 R35 R36 R37 R38 
A
ex
t 
Glc -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.0208 0 
Lac 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
NH4 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 1 0 0 1 1 0 0 0 0 1 1 0 0 1 0 0 0 
Gln 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 -1 -0.0377 0 
Glu 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 -1 -1 -1 0 0 0 0 -1 0 0 0 1 1 -1 1 1 -0.0006 0 
Arg 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 -0.007 0 
His 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 -0.0033 0 
Ile 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.0084 0 
Leu 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.0133 0 
Lys 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.0101 0 
Met 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.0033 0 
Phe 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 -0.0055 0 
Thr 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.008 0 
Trp 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 -0.004 0 
Val 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.0096 0 
Ala 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 -0.0133 0 
Asn 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 1 0 0 
Asp 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 -1 -0.026 0 
Cys 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 -0.0004 0 
Gly 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 1 0 0 0 0 0 0 0 -0.0165 0 
Pro 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 +1 0 0 -0.0081 0 
Ser 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 -1 0 0 1 -1 0 0 0 0 0 0 0 -0.0099 0 
Tyr 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 -1 0 0 1 0 0 0 0 0 0 -0.0077 0 
Bio. 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 -1 
C death 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 
A
in
t 
G6P 1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
3-phos. 0 2 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 0 
Pyr 0 0 1 -1 -1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 -1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 
AcCoA 0 0 0 0 1 -1 0 0 0 0 0 0 1 2 0 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Cit 0 0 0 0 0 1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
KG 0 0 0 0 0 0 1 -1 0 0 0 0 0 0 1 0 0 0 0 0 1 1 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 
SucCoa 0 0 0 0 0 0 0 1 -1 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Suc 0 0 0 0 0 0 0 0 1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 
Mal 0 0 0 0 0 0 0 0 0 1 -1 -1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Oxal 0 0 0 0 0 -1 0 0 0 0 1 0 0 0 0 0 0 1 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
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APPENDIX B: Media composition 
 
Table B.1. Composition of SF10 and SF14 medium compared with DMEM/F12 
  COMPONENT DMEM/F12 ADD. 1 SF10 ADD. 2 SF14 
   mg/L mg/L mg/L  mg/L 
A
m
in
o
 a
ci
d
s 
Alanine 4.45  4.45  4.45 
Arginine-HCl 147.5  147.5  147.5 
Asparagine•H2O 7.5  7.5  7.5 
Aspartic acid 6.65  6.65  6.65 
Cysteine•HCl•H2O 28.3  28.3  28.30923275 
Cystine 18.7  18.7  18.74462692 
Glutamate 7.35  7.35  7.35 
Glutamine 365  365  365 
Glycine 18.75  18.75  18.75 
Histidine 31.48  31.48  31.48 
Isoleucine 54.47  54.47  54.47 
Leucine 59.05  59.05  59.05 
Lysine•HCl 91.25  91.25  91.25 
Methionine 17.24  17.24  17.24 
Phenylalanine 35.48  35.48  35.48 
Proline 17.25  17.25  17.25 
Serine 26.25  26.25  26.25 
Threonine 53.45  53.45  53.45 
Tryptophan 9.02  9.02  9.02 
Tyrosine•HCl 55.79  55.79  55.79 
Valine 52.85  52.85  52.85 
 O
rg
a
n
. V
it
a
m
in
s 
Sodium Pyruvate 110  110  110 
Biotin 0.0035  0.0035  0.0035 
Calcium pantothenate 2.24  2.24  2.24 
Choline chloride 8.98  8.98  8.98 
Folic acid 2.66  2.66  2.66 
Myo-Inositol 12.6  12.6 60 72.6 
Nicotinamide 2.02  2.02 4 6.02 
Pyridoxine•HCl 2.031  2.031  2.031 
Riboflavin 0.219  0.219  0.219 
Thiamine•HCl 2.17  2.17  2.17 
Vitamin B12 0.68  0.68  0.68 
S
a
lt
s/
m
e
ta
ls
/
tr
a
ce
 
CaCl2 116.6632653  116.6632653  116.6632653 
KCl 311.8  311.8  311.8 
Na2HPO4 71.02  71.02  71.02 
NaCl 6996  6996  6996 
NaH2PO4•H2O 62.445  62.445  62.445 
MgSO4 48.84  48.84  48.84 
MgCl2 28.68844073  28.68844073  28.68844073 
NaHCO3  2.200 2200 2200 2200 
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Sodium Selenite 0.00519  0.00519  0.00519 
Ferric Citrate   0 0.25 0.25 
CuSO4 •5H2O 0.0013  0.0013  0.0013 
FeSO4 •7H2O 0.417  0.417  0.417 
ZnCl 0.432  0.432  0.432 
MnSO4 •H2O 0.000169  0.000169  0.000169 
Na2SiO3 •9H2O 0.0142  0.0142  0.0142 
(NH4) 6Mo7O24 •4H2O 0.015525366  0.015525366  0.015525366 
NiSO4 •6H2O 0.00022  0.00022  0.00022 
SnCl2 •2H2O 7.85714E-05  7.85714E-05  7.85714E-05 
M
is
ce
ll
a
n
e
o
u
s 
Putrescine•2HCl 0.081  0.081 0.95 1.031 
Linoleic acid 0.042  0.042  0.042 
Lipoic acid 0.105  0.105  0.105 
Pluronic F-68  1000 1000 1000 1000 
Insulin  15 15 5 5 
Hipoxantine   20 20 20 
Thymidine   5.0 5 5 
Glucose  3150 3.150.0 3150 3150 
Phenol red  8.63 8.6 8.63 8.63 
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Table B.2. Concentration stock Solution of the components used 
  COMPONENT7 
Dissolution   
in Concentration Stock Solution 
      mg/L 
A
m
in
o
 a
ci
d
s 
Alanine Water 15000 
Arginine-HCl Water 49125 
Asparagine•H2O HCL 1N 7500 
Aspartic acid Water 6650 
Cysteine•HCl•H2O Water 24000 
Cystine HCL 2N 9370 
Glutamate Water 7350 
Glycine Water 18750 
Histidine Water 25000 
Isoleucine HCL 1N 27235 
Leucine HCL 1N 29525 
Lysine•HCl Water 91250 
Methionine Water 17240 
Phenylalanine HCL 1N 35480 
Proline Water 17250 
Serine Water 26250 
Threonine Water 53450 
Tryptophan HCL 2N 9020 
Tyrosine•HCl HCL 1N 14000 
Valine Water 10570 
 O
rg
a
n
. V
it
a
m
in
s 
Sodium Pyruvate Water 55000 
Biotin NaOH 2M 4.17E+03 
Calcium pantothenate Water 336 
Choline chloride Water 25000 
Folic acid Water 25000 
Myo-Inositol Water 25000 
Nicotinamide Water 2000 
Pyridoxine•HCl Water 2000 
Riboflavin NaOH 0.1M 4.33E+03 
Thiamine•HCl Water 2000 
Vitamin B12 Water 10200 
S
a
lt
s/
m
e
ta
ls
/
tr
a
ce
 
CaCl2 Water 100000 
KCl  Water 44000 
Na2HPO4  Water 33000 
NaH2PO4•H2O  Water 100000 
MgSO4  Water 50000 
MgCl2  Water 72000 
Sodium Selenite Water 1.07 
Ferric Citrate  Water 500 
CuSO4 •5H2O Water 1000 
FeSO4 •7H2O HCL 1N 500 
                                                        
7 The components not listed were added directly in the medium 
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ZnCl Water 300 
MnSO4 •H2O  Water 0.33 
Na2SiO3 •9H2O  Water 50 
(NH4) 6Mo7O24 •4H2O  Water 11700 
NiSO4 •6H2O  Water 66 
SnCl2 •2H2O  Water 6.07E+03 
 
M
is
ce
ll
a
-
n
e
a
o
u
s 
  
Putrescine•2HCl Water 250 
Linoleic acid  Water 6300 
Lipoic acid Ethanol 400 
Insulin Water 5000000 
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APPENDIX C: RMB03.02 experiment 
 
 
Experiment RMB03.02 was carried out varying the aa concentration in the medium 
in the different tubes in order to trigger different metabolic pathways.  
 
The data were analyzed for modelling. Unfortunately, the cells did not grow 
significantly or not at all in SF10 medium. The aa variations were small and several 
problems were encountered. 
 
The two methods used in the AAA, AccQTag and AccQTagComplete, did not separate 
properly all the aa peaks. In the first method, two pairs of aa were eluated together: 
Asn with Ser and His with Gln. In contrast, in the second method, only NH3 and His 
were eluated together.  This affected the calculation of the concentration of the aa. 
 
In general, the concentrations of the aa were obtained doing the average of the 
concentrations of each method. In the case of Asn, Ser and Gln the concentration 
was obtained only using the concentration of the method where the peak was 
correctly separated instead. 
 
The Histidine concentration was more complicated to solve. At first, three possible 
solutions were thought. These solutions used the concentration values where the 
Histidine was involved and the concentration of the components that eluated 
together with it: 
 
 Table C.1. Possible solutions to determine His concentration 
1. His (His Gln)AccQTag (Gln)AccQTagComplete 
2. His (His Gln)AccQTag (Gln)Bioprofile  
3. His (His NH3)AccQTagComplete (NH3)AccQTag  
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Unfortunately, none of the described solutions were good enough since in many 
cases the concentration of Histidine was negative which is not possible. HPLC is not 
a totally accurate technique. Furthermore, the values that come from the Bioprofile 
and HPLC were not completely correlated.  
 
Finally, the first option was decided since it was the case where less Histidine 
concentrations became negative. However, too many values of His were negative, so 
this aa was not taken into account in the simulation.  
 
A second problem appeared when the qi, consumption/production rates, were 
calculated using Eq. 6. So, according to this formula, when the value of qi is negative, 
it means that the amino acid is produced and when it is positive it means that the 
amino acid is consumed.  According to that, the qi of the essential amino acids were 
supposed to be positive but, unfortunately, it did not always occur.   
 
From the data it seemed that some essential amino acids were produced since some 
values of the culture concentrations were above the concentration in fresh medium. 
This was due to the low consumption of the aa. It suggested that the measurements 
by HPLC of the concentrations of the essential amino acids in the medium were not 
accurate. In order to be able to use these data as input in the simulation program, 
one possible solution was to consider that the measurements of the concentrations 
of the eaa in the medium were erroneous and to identify better values for these 
concentrations. 
 
A first approach was to take the average of the values of day 3, which could be also 
considered the first day of the steady state, of all the experiments. Nevertheless, this 
approach could not been used in all the essential aa. In some cases the 
concentrations from day 3 were very different and the average was not a good 
solution. This was the case of Trp (Fig. C.1.a). In others, the evolution of the 
concentration of the essential aa over time increased and the problem remained 
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after the application of the average of day 3. This was the case of Ile (Fig. C.1.b). In 
this cases the criteria decided was to take the maximum value of the concentrations. 
 
The graphics in Fig. C.1, where the evolution of each essential amino acid and the 
maximum value appear, helped to arrive to a final decision. In that case the graphics 
in Fig. C.1 show the final input concentration.  
 
                         
                         
(a)Tryptophan                                                                                  (b) Isoleucine  
 
 
 
 
 
 
 
 
 
 
 
 
(c) Methionine 
Figure C.1. Graphics used to obtain the criteria for the first alternative 
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The final criteria decided were: 
 
Table C.2. Criteria for first alternative 
Arginine 
Average: CT2, CT3, CT6, CT7, CT9, CT12 
CT1: maximum value 
Isoleucine Maximum value 
Leucine Maximum value 
Lysine Maximum value 
Methionine 
Average: CT2, CT3, CT6, CT7, CT9, CT12 
CT1: first value 
Phenylalanine 
Average: CT2, CT3, CT6, CT7, CT9 
CT2 and CT12: maximum value 
Threonine 
Average: CT2, CT3, CT6, CT7, CT9, CT12 
CT1: first value 
Tryptophan Maximum value 
Valine Maximum value 
 
According to the results, there were still consumption/production rates that 
neglected the definition of an essential amino acid and they are showed in Table C.3. 
 
Table C.3. Eaa which specific consumption/production rate was above zero after the application of 
the first criteria 
 Day 4 Day 5 Day 6 
CT1 
Arg, Ile, Leu, Lys, Met, 
Phe, Thr, Trp, Val 
Lys Ile, Leu, Lys, Met, Phe, 
Val 
CT2 
Ile Ile, Lys Ile, Leu, Lys, Met, Phe, 
Thr, Trp, Val 
CT3 Ile, Thr Ile, Leu, Lys, Met, Val  
CT6 
Arg, Met, Phe, Thr, 
Trp 
Ile, Leu, Lys, Met, Val Arg, Ile, Leu, Lys, Met, 
Phe, Thr, Val  
CT7 
Arg, Met, Phe, Thr, 
Trp 
Ile, Leu, Lys Ile, Leu, Lys, Met, Phe, 
Val 
CT9 
Trp Ile, Leu, Lys, Met, Thr, 
Val 
Ile, Met, Phe 
CT12 
 Ile, Leu, Lys, Met, Val, 
Thr 
 
 
As can be seen in Table C.3 only three days could be used, but they were not enough 
since the inequation in Eq. 26 would not be fulfilled. For that reason, a second 
alternative was needed. This second criterion, which was a more dramatic change, 
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used directly as a concentration input the maximum value of the concentrations of 
each experiment. The next table shows, which essential amino acids continue to be 
negative after the changing described above.  
 
Table C.4. EAA that have specific consumption/production negative rate after application second 
criteria 
 Day 4 Day 5 Day 6 
CT1 
Arg, Ile, Leu, Lys, Met, 
Phe, Thr, Trp, Val 
Lys Ile, Leu, Lys, Met, Phe, 
Val 
 
CT2 
Ile Ile, Lys Ile, Leu, Lys, Met, Phe, 
Thr, Trp, Val 
CT3 
Ile, Thr Ile, Leu, Lys, Met, Phe, 
Val 
 
CT6 
Arg, Met, Phe, Thr, 
Trp 
Ile, Leu, Lys, Met, Val Arg, Ile, Leu, Lys, Met, 
Phe, Thr, Val  
CT7 
Arg, Met, Phe, Thr, 
Trp 
Ile, Leu, Lys Ile, Leu, Lys, Met, Phe, 
Val 
CT9 
Trp Ile, Leu, Lys, Met, Thr, 
Val 
Ile, Met, Phe 
CT12 
 Ile, Leu, Lys, Met, Val, 
Thr 
 
 
 
Despite that this alternative was the most dramatic change that could be done with 
the concentration of the fresh medium, there were still some 
consumption/production rates that were negative.  
 
As a consequence of that, the first attempt could not be directly used in the 
simulation program and the only possibility to use it was to make some 
simplifications of the system.  These simplifications discarded some eaa where the 
consumption/production rates were negative in order to be able to use some 
samples as input in the simulation program. 
 
Several options and systems were used but, unfortunately, the results obtained 
were not good. Thus, it was decided not to continue with the analysis of the results 
of this experiment. 
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APPENDIX D: Experiment 2 
Table D.1. Cv and Viabilite of CT1 and CT2 
Exp CT1 Ala 0%  Exp CT2 Ala 50% 
Sampling time  Cult. time Cv Viability  Sampling time  Cult. time  Cv Viability 
day  days  MVC/mL %  day  days  MVC/mL % 
09/04/10 01:30  -      0.5  -       09/04/10 01:30  -      0.5  -      
11/04/10 10:59  2    1.675 99.6  11/04/10 11:06  2    1.362 98.5 
12/04/10 01:03  3    2.041 93.4  12/04/10 02:02  3    1.778 93.7 
13/04/10 01:28  4    0.634 66  13/04/10 01:33  4    0.581 71 
14/04/10 01:58  5    0.56 65.9  14/04/10 02:06  5    0.44 59.9 
15/04/10 02:48  6    0.842 82.9  15/04/10 11:52  6    0.516 66.7 
16/04/10 01:05  7    1.256 87.4  16/04/10 01:20  7    0.867 85.4 
17/04/10 01:01  8    1.1 89  17/04/10 01:59  8    0.959 87.8 
     18/04/10 12:15  9    1.265 91.3 
  
Table D.2. Cv and Viabilite of CT3 and CT4 
Exp CT3 Ser 0%  Exp  CT4 Ser 50% 
Sampling time  Cult. time  Cv Viability  Sampling time  Cult. time  Cv Viability 
day  days  MVC/mL %  day  days  MVC/mL % 
09/04/10 01:30  -      0.5  -       09/04/10 01:30  -      0.5  -      
11/04/10 11:14  2    1.449 98.7  11/04/10 11:26  2    1.507 98.1 
12/04/10 02:09  3    1.782 95.7  12/04/10 02:21  3    1.825 93.7 
13/04/10 01:46  4    0.608 68.1  13/04/10 01:52  4    0.47 66.1 
14/04/10 03:48  5    0.462 0.638  14/04/10 03:00  5    0.44 65.9 
15/04/10 02:54  6    0.61 82.7  15/04/10 04:47  6    0.456 74.5 
16/04/10 03:22  7    0.937 92  16/04/10 03:29  7    0.602 80.7 
17/04/10 02:08  8    1.173 92.1  17/04/10 01:10  8    0.931 85.2 
18/04/10 12:22  9    1.512 96.5      
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Table D.3. Cv and Viabilite of CT5 and CT6 
Exp CT5 Asp 0%  Exp CT6 Asp 50% 
Sampling time  Cult. time Cv Viability  Sampling time  Cult. time  Cv Viability 
day  days  MVC/mL %  day  days  MVC/mL % 
09/04/10 01:30  -      0.5  -       09/04/10 01:30  -      0.5  -      
10/04/10 01:00  1     -       -       10/04/10 01:00  1     -       -      
11/04/10 11:45  2    1.515 99  11/04/10 11:52  2    1.515 99.2 
12/04/10 02:28  3    1.665 95.2  12/04/10 02:34  3    1.329 93 
13/04/10 03:25  4    0.86 75  13/04/10 03:31  4    0.975 80.5 
14/04/10 05:00  5    0.914 84.5  14/04/10 02:35  5    1.144 91 
15/04/10 03:05  6    1.3 88.8  15/04/10 03:11  6    1.78 96.7 
16/04/10 03:36  7    1.271 91.6  16/04/10 03:52  7    1.613 98.5 
17/04/10 01:21  8    1.387 92.5  17/04/10 01:30  8    1.529 98.4 
 
Table D.4. Cv and Viabilite of CT7 and CT8 
Exp CT7 Glu 0%  Exp CT8  Glu 50% 
Sampling time  Cult. time  Cv Viability  Sampling time  Cult. time  Cv Viability 
day  days  MVC/mL %  day  days  MVC/mL % 
09/04/10 01:30  -      0.5  -       09/04/10 01:30  -      0.5  -      
11/04/10 11:58  2    1.757 99.5  11/04/10 12:04  2    1.395 99.2 
12/04/10 02:43  3    1.92 93.6  12/04/10 02:55  3    1.631 89.9 
13/04/10 03:40  4    0.929 77.8  13/04/10 03:46  4    0.47 49.6 
14/04/10 03:04  5    0.97 82.8  14/04/10 03:10  5    0.426 56.7 
15/04/10 03:53  6    1.784 89.6  15/04/10 11:38  6    0.646 67.8 
16/04/10 03:59  7    1.239 94.9  16/04/10 04:20  7    0.896 81 
17/04/10 01:37  8    1.515 95.3  17/04/10 02:21  8    1.026 91.6 
     18/04/10 12:31  9    1.418 94.4 
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Table D.5. Cv and Viabilite of CT9 and CT10 
Exp CT9 Gly 0%  Exp CT10 Gly 50% 
Sampling time  Cult. time  Cv Viability  Sampling time  Cult. time  Cv Viability 
day  days  MVC/mL %  day  days  MVC/mL % 
09/04/10 01:30  -      0.5  -       09/04/10 01:30  -      0.5  -      
10/04/10 01:00  1     -       -       10/04/10 01:00  1     -       -      
11/04/10 12:11  2    1.592 99.4  11/04/10 02:00  2    1.75 96.1 
12/04/10 03:07  3    1.565 91.6  12/04/10 03:14  3    1.503 94 
13/04/10 03:52  4    0.914 73.6  13/04/10 05:14  4    0.746 68.1 
14/04/10 04:54  5    0.73 79  14/04/10 05:02  5    0.776 80.7 
15/04/10 11:54  6    0.72 75.9  15/04/10 04:04  6    1.288 89.1 
16/04/10 04:29  7    0.27 58.7  16/04/10 04:59  7    1.308 92.2 
     17/04/10 01:44  8    1.372 93.3 
 
Table D.6. Cv and Viabilite of CT11 and CT12 
Exp CT11 Asn 0%  Exp CT12 Asn 50% 
Sampling time  Cult. time  Cv Viability  Sampling time  Cult. time  Cv Viability 
day  days  MVC/mL %  day  days  MVC/mL % 
09/04/10 01:30  -      0.5  -       09/04/10 01:30  -      0.5  -      
11/04/10 02:20  2    1.67 94.1  11/04/10 02:35  2    1.77 97.2 
12/04/10 03:35  3    1.548 94.5  12/04/10 03:28  3    1.861 93 
13/04/10 05:30  4    0.711 64.8  13/04/10 05:38  4    0.516 56.9 
14/04/10 05:08  5    0.874 78.1  14/04/10 05:06  5    0.403 59.8 
15/04/10 04:11  6    1.49 89.1  15/04/10 04:17  6    0.608 62.7 
16/04/10 05:07  7    1.375 93.2  16/04/10 05:14  7    0.624 63.1 
17/04/10 01:51  8    1.181 94.5  17/04/10 02:29  8    0.725 78.7 
     18/04/10 12:37  9    0.73 81.9 
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Table D.7. Cv and Viabilite of CT13 and CT14 
Exp CT13 EAA 50%  Exp CT14 ctrl 
Sampling time  Cult. time  Cv Viability  Sampling time  Cult. time  Cv Viability 
day  Days  MVC/mL %  day  days  MVC/mL % 
09/04/10 01:30  -      0.5  -        #¡REF! #¡REF! #¡REF! 
10/04/10 01:00  2  1.48       97.6      09/04/10 01:30  -      0.5  -      
12/04/10 03:36  3    1.834 92  11/04/10 03:15  2    1.48 96 
13/04/10 05:44  4    0.418 48.7  12/04/10 03:49  3    1.264 92.8 
14/04/10 03:30  5    0.28 42.5  13/04/10 02:02  4    0.837 84.7 
15/04/10 04:22  6    0.572 73.8  14/04/10 11:35  5    0.916 86.1 
16/04/10 05:20  7    0.401 54.2  15/04/10 12:45  6    1.104 90.4 
     16/04/10 05:30  7    1.486 93.1 
     17/04/10 02:36  8    1.429 95.7 
     18/04/10 12:45  9    1.284 96.5 
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Table D.8.Concentration of the external metabolites of the samples used in the complete system 
Component CT1D06 CT1D07 CT2D08 CT4D06 CT5D06 CT5D07 CT5D08 CT6D06 CT6D07 CT6D08 CT10D05 
Glc 14.18 14.24 16.93 15.82 14.33 14.18 15.98 12.63 13.08 13.75 15.44 
Lac 3.50 5.40 6.08 1.53 4.12 4.19 3.94 8.65 6.06 7.08 2.47 
Gln 2.21 2.94 2.90 2.34 1.98 2.92 2.86 1.70 2.63 2.71 2.34 
NH4 0.96 1.18 1.38 0.76 1.22 1.45 1.36 1.17 1.54 1.40 0.82 
Asp 0.05 0.04 0.04 0.04 0.03 0.04 0.04 0.02 0.04 0.04 0.06 
Glu 0.15 0.17 0.19 0.12 0.13 0.20 0.19 0.13 0.18 0.15 0.20 
Ser 0.42 0.48 0.43 0.41 0.48 0.49 0.49 0.45 0.49 0.46 0.46 
Asn 0.04 0.04 0.08 0.02 0.03 0.09 0.10 0.04 0.10 0.09 0.04 
Gly 0.30 0.24 0.23 0.26 0.23 0.29 0.27 0.16 0.24 0.24 0.16 
His 0.27 0.22 0.25 0.20 0.22 0.26 0.28 0.20 0.26 0.26 0.35 
Thr 0.58 0.50 0.53 0.43 0.44 0.58 0.58 0.40 0.54 0.49 0.69 
Arg 0.85 0.75 0.84 0.64 0.70 0.96 1.01 0.69 0.91 0.87 1.10 
Ala 0.38 0.51 0.67 0.29 0.48 0.76 0.73 0.70 0.94 0.75 0.55 
Pro 0.20 0.15 0.15 0.15 0.15 0.18 0.18 0.10 0.17 0.15 0.29 
Tyr 0.33 0.32 0.32 0.25 0.28 0.38 0.35 0.26 0.36 0.29 0.45 
Cys 0.27 0.24 0.20 0.18 0.09 0.22 0.22 0.08 0.18 0.11 0.34 
Val 0.46 0.40 0.41 0.35 0.45 0.51 0.49 0.35 0.43 0.40 0.63 
Met 0.10 0.08 0.07 0.07 0.08 0.11 0.12 0.07 0.09 0.05 0.16 
Iso 0.41 0.37 0.39 0.32 0.33 0.45 0.44 0.31 0.42 0.38 0.54 
Leu 0.42 0.39 0.39 0.34 0.33 0.46 0.44 0.29 0.42 0.39 0.55 
Lys 0.62 0.61 0.65 0.53 0.58 0.71 0.71 0.51 0.69 0.67 0.85 
Phe 0.26 0.23 0.26 0.09 0.10 0.29 0.30 0.12 0.26 0.11 0.35 
Tryp 0.05 0.04 0.07 0.05 0.06 0.04 0.03 0.02 0.05 0.01 0.06 
Biomass 842.00 1256.00 1265.00 456.00 1300.00 1271.00 1387.00 1780.00 1613.00 1529.00 776.00 
Death 173.68 181.07 120.54 156.08 163.96 116.55 112.46 60.74 24.56 24.86 185.59 
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Table D.9.Specific consumption/production rates of the samples used in the complete system 
Component CT1D06 CT1D07 CT2D08 CT4D06 CT5D06 CT5D07 CT5D08 CT6D06 CT6D07 CT6D08 CT10D05 
Glc -4.65 -3.04 -0.37 -3.54 -2.81 -2.98 -1.19 -3.42 -3.44 -3.02 -2.71 
Lac 5.21 5.37 6.03 3.66 3.90 4.00 3.55 6.34 4.94 6.03 3.60 
Gln -2.52 -0.95 -0.99 -3.73 -1.82 -0.94 -0.94 -1.61 -1.04 -1.01 -2.27 
NH4 1.43 1.17 1.37 1.82 1.16 1.38 1.23 0.86 1.26 1.19 1.19 
Asp -0.02 -0.02 -0.01 -0.10 0.01 0.02 0.01 0.02 0.03 0.04 -0.01 
Glu 0.09 0.08 0.10 0.11 0.05 0.12 0.10 0.02 0.07 0.05 0.13 
Ser -0.05 0.03 0.07 0.36 0.03 0.04 0.04 0.02 0.06 0.03 0.18 
Asn 0.01 0.01 0.05 0.04 -0.01 0.05 0.05 -0.01 0.04 0.04 -0.08 
Gly -0.22 -0.22 -0.17 -0.52 -0.25 -0.19 -0.20 -0.25 -0.22 -0.23 -0.16 
His -0.07 -0.09 -0.02 -0.19 -0.09 -0.05 -0.03 -0.11 -0.07 -0.07 -0.07 
Thr -0.21 -0.22 -0.06 -0.41 -0.21 -0.07 -0.07 -0.22 -0.13 -0.17 -0.13 
Arg -0.33 -0.31 -0.02 -0.51 -0.31 -0.07 -0.03 -0.31 -0.17 -0.21 -0.20 
Ala 0.57 0.51 0.65 0.27 0.30 0.57 0.51 0.40 0.63 0.51 0.55 
Pro -0.09 -0.10 -0.08 -0.17 -0.11 -0.07 -0.08 -0.13 -0.09 -0.11 -0.08 
Tyr -0.17 -0.12 -0.09 -0.25 -0.18 -0.08 -0.11 -0.18 -0.12 -0.18 -0.17 
Cys -0.11 -0.11 -0.09 -0.17 -0.25 -0.13 -0.12 -0.21 -0.15 -0.21 -0.11 
Val -0.22 -0.20 -0.12 -0.36 -0.18 -0.12 -0.14 -0.23 -0.18 -0.22 -0.19 
Met -0.04 -0.04 -0.05 -0.12 -0.07 -0.04 -0.03 -0.06 -0.05 -0.09 -0.04 
Iso -0.20 -0.17 -0.08 -0.35 -0.22 -0.11 -0.11 -0.22 -0.15 -0.20 -0.17 
Leu -0.32 -0.24 -0.16 -0.46 -0.28 -0.15 -0.17 -0.29 -0.21 -0.25 -0.31 
Lys -0.29 -0.21 -0.05 -0.46 -0.23 -0.11 -0.10 -0.26 -0.15 -0.17 -0.16 
Phe -0.10 -0.09 -0.02 -0.09 -0.25 -0.07 -0.06 -0.17 -0.07 -0.20 -0.09 
Tryp -0.01 -0.02 -0.03 -0.01 -0.06 -0.07 -0.08 -0.05 -0.03 -0.07 -0.02 
Biomass 1154.97 795.86 793.88 1005.84 758.16 764.32 722.22 586.41 652.67 681.59 1041.28 
Death 260.02 180.62 120.15 375.60 155.85 111.87 101.97 44.83 20.43 21.61 271.68 
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APPENDIX E: Code 
 
 
 calcAmac: calculates stoichiometric matrix of the 
macroscopic reactions 
 
function 
[Amac,EM,nmodes,externalreactions]=calcAma
c(Aext,Aint,irrev) 
  
[MET,J]=size(Aext); 
  
%Calc AEM (Stoichiometric matrix of 
internal metabolites) and AeEM 
%(Stoichiometric matrix of external 
metabolites) 
ne=0; 
ni=0; 
for j=1:J 
    if norm(Aint(:,j))==0 
        ne=ne+1; 
        AeEM.ext(:,ne)=Aext(:,j); 
        AeEM.irrev_react(ne)=irrev(:,j); 
        externalreactions(ne)=j;       
    else 
        ni=ni+1; 
        AEM.ext(:,ni)=Aext(:,j); 
        AEM.st(:,ni)=Aint(:,j); 
        AEM.irrev_react(ni)=irrev(:,j); 
    end 
end 
if ne==0 
   AeEM.ext=0; 
else 
end 
if ni==0 
   AEM.ext=0; 
   AEM.st=0; 
   AEM.irrev_react=0; 
else 
end 
%Calc internal elementary modes using 
metatool 
AEM= metatool(AEM); 
AEM.ems= AEM.sub' * AEM.rd_ems; 
  
%Calc macro reactions of the internal 
elementary modes 
  
AmacEM=AEM.ext*AEM.ems; 
  
[aux,numbermodesi]=size(AmacEM); 
  
%Calc number of external irrev reaction 
nei=0; 
for j=1:ne 
    if AeEM.irrev_react(j)==0 
        nei=nei+1; 
    else 
    end 
end 
  
%Calc external elementary modes 
AeEM.ems=zeros(ne,nei+ne); 
eem=0; 
for j=1:ne 
        eem=eem+1; 
        AeEM.ems(j,eem)=1; 
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        if AeEM.irrev_react(j)==0; 
            eem=eem+1; 
            AeEM.ems(j,eem)=-1; 
        else 
        end 
end 
  
%Calc macro reactions of external elem 
modes 
AmaceEM=AeEM.ext*AeEM.ems; 
  
%Calc Amac 
if ni==0 
    Amac=AmaceEM; 
else 
    Amac=[AmacEM AmaceEM]; 
end 
  
%Calc number of EMs 
nmodes=numbermodesi+ne+nei; 
  
%Calc EMs from the internal and external 
elementary modes matrixes and set 
%the reactions order of the beginning 
if ni==0 
    EM=AeEM.ems; 
    nmodes=nmodes-1; 
else 
     
    EM=zeros(j,nmodes); 
    nee=1; 
    nii=1; 
    for j=1:J 
        if externalreactions(nee)==j         
            EM(j,:)=[zeros(1,numbermodesi) 
AeEM.ems(nee,:)]; 
            nee=nee+1; 
        else 
            EM(j,:)=[AEM.ems(nii,:) 
zeros(1,ne+nei)]; 
            nii=nii+1; 
        end 
    end 
end     
 
 
 
 calcmus: calculates the values of the maximal kinetic 
rates j 
 
function [MU,error]=calcmus(A,Q,C,K) 
  
[MET,J]=size(A); 
[MET,NS]=size(Q); 
  
%Calculate the average value for every 
metabolite 
AVERAGE=zeros(MET,1); 
for met=1:MET 
    AVERAGE(met)=norm(Q(met,:),1)/NS; 
end 
  
%Create R 
R=zeros(1,J*NS); 
  
%Create B 
B=zeros(MET*NS,J); 
  
%Calculate Qnorm 
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Qnorm=zeros(MET,NS); 
for met=1:MET 
    Qnorm(met,:)=Q(met,:)/AVERAGE(met); 
end 
  
%Create Qt and Ct 
Qt=zeros(MET*NS,1); 
Ct=zeros(MET*NS,1); 
for ns=1:NS 
    Qt(MET*(ns-1)+1:MET*ns)=Qnorm(:,ns); 
    Ct(MET*(ns-1)+1:MET*ns)=C(:,ns); 
end 
 %Calculate B 
for ns=1:NS 
    %Calculate R's such 
averagei*bij=aij*rij; 
rij=multj((S^aij/(Ki+S)^aij) 
    for j=1:J 
        R(j+J*(ns-1))=1; 
        for met=1:MET 
 
 
            if A(met,j)<0 
                R(j+J*(ns-1))=R(j+J*(ns-
1))*Ct(met+MET*(ns-1))^(-
A(met,j))/(K(met)+Ct(met+MET*(ns-1)))^(-
A(met,j)); 
            else 
            end 
        end 
    end 
  
    %Calculate B 
    for met=1:MET 
        for j=1:J 
            B(met+MET*(ns-1),j)=R(j+J*(ns-
1))*A(met,j)/AVERAGE(met); 
        end 
    end 
end 
for i=1:NS 
    t(i,:)=B(17+(i-1)*MET,:); 
end 
t 
%Calculate MU using lsqnonneg 
%optional, if is wanted to force a 
starting value for the iterations:  
x0=0*ones(1,J); 
[MU,error] = lsqnonneg(B,Qt,x0); 
  
%Calculate error=norm 
error=sqrt(error); 
 
 
 calcredsys: calculates the reduced system using the 
stoichiometric matrix of the macroscopic reactions and 
the maximal kinetic rates  
 
function[Ared,MUred]=calcredsys(A,MU) 
[MET,NR]=size(A); 
%Count the number of reactions to not 
create variables that grow inside a 
%loop 
nrred=0; 
for nr=1:NR     
    if MU(nr)==0 
    else 
        nrred=nrred+1; 
    end 
 101 
end 
%Calculate Ared and MUred 
MUred=zeros(nrred,1); 
Ared=zeros(MET,nrred); 
nrred=0; 
for nr=1:NR     
    if MU(nr)==0 
    else 
        nrred=nrred+1; 
        Ared(:,nrred)=A(:,nr); 
        MUred(nrred)=MU(nr); 
    end 
end 
 
 
 findmodel: combination of the three above functions  
 
function[Ared,MUred,error,Amac,MU,EM,nmode
s,externalreactions]=findmodel(Aext,Aint,i
rrev,Q,C,K) 
%calculate macroscopic reactions 
[Amac,EM,nmodes,externalreactions]=calcAma
c(Aext,Aint,irrev); 
  
  
  
%Check the cidnition MET*NS>J; 
metabolites*samples>elementary modes 
J=size(Amac,2); 
[MET,NS]=size(Q); 
  
%if MET*NS<J 
%    msgBox('Warning: the number of 
metabolites*the number of samples < the 
number of elementary modes, solution can 
be non-optimal*/','Error'); 
%end 
  
%calc kinetic rates 
[MU,error]=calcmus(Amac,Q,C,K); 
%calc reduced system 
[Ared,MUred]=calcredsys(Amac,MU); 
 
 
 calcrates: predicts the specific 
consumption/production rates of all the external 
metabolites using the reduced system 
 
function [Qcalc]=calcrates(A,MU,C,K,Q) 
  
NS=size(C,2); 
[MET,J]=size(A); 
Qcalc=zeros(MET,NS); 
%Create B*MU 
B=zeros(MET,J); 
%Create R 
R=zeros(1,J); 
for ns=1:NS 
    %Calculate R's 
    for j=1:J     
        R(j)=1; 
        for met=1:MET 
            if A(met,j)<0  %if it is 
substract 
                R(j)=R(j)*C(met,ns)^(-
A(met,j))/(K(met)+C(met,ns))^(-A(met,j)); 
            end 
        end 
    end 
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    %Calculate B*MU 
    for met=1:MET 
        for j=1:J 
            B(met,j)=R(j)*A(met,j); 
        end 
    end 
    %Calc Qcalc 
    Qcalc(:,ns)=B*MU; 
    if ns==6 
        B(6,:)'; 
    end 
end 
 
 
 plotQ: plots qexp and qest in the same plot. Each plot 
represents one day of one CT for the metabolites that 
have higher q’s: Glc, Lac, NH4, Gln and Biomass 
 
function 
plotQ(Q,Qcalc,experiments,plotcol) 
[MET,J]=size(Q); 
figure 
plotrows=ceil(J/plotcol); 
for ns=1:J 
    subplot(plotrows,plotcol,ns) 
    %The position of these metabolites can 
change between systems 
    a1=Q(1:4,ns)'; %Glc, Lac, NH4 and Gln  
    a2=Q(24,ns); %Biomass 
    a=[a1,a2]; 
    plot((1:5),a,'b'); 
    hold 
    b1=Qcalc(1:4,ns)'; 
    b2=Qcalc(24,ns); 
    b=[b1,b2]; 
    plot((1:5),b,'r'); 
    grid on 
    title(experiments(ns)); 
    xlabel('Metabolites'); 
    ylabel('Consumption/production 
[nmol/(MVC∑day)]'); 
    axis ([1 5 -4200 6100])  
end 
 
 
 plotQ2: the same as before but for the rest of the 
metabolites 
 
function 
plotQ2(Q,Qcalc,experiments,plotcol) 
[MET,J]=size(Q); 
figure 
plotrows=ceil(J/plotcol); 
for ns=1:J 
    subplot(plotrows,plotcol,ns) 
    a1=Q(5:23,ns)'; %Rest of the 
metabolites 
    a2=Q(MET,ns); %Cell death 
    a=[a1,a2]; 
    plot((6:MET),a,'b'); 
    hold 
    b1=Qcalc(5:23,ns)'; 
    b2=Qcalc(MET,ns); 
    b=[b1,b2]; 
    plot((6:MET),b,'r'); 
    grid on 
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    title(experiments(ns)); 
    xlabel('Metabolites'); 
    ylabel('Consumption/production 
[nmol/(MVC∑day)]'); 
    axis([5 25 -600 650]) 
end 
 
 
 calculate_errorabsolute: calculates the error between 
experimental q and estimated q in % for each samples 
and metablite and the average for all the metabolites 
 
function 
[ERROR,error_metabolite]=calculate_errorab
solut(Q,Qcalc) 
  
[MET,J]=size(Q); 
ERROR=zeros(MET,J); 
error_metabolite=zeros(1,MET); 
for met=1:MET 
    ERROR(met,:)=(Q(met,:)-
Qcalc(met,:))./Q(met,:); 
end 
for met=1:MET 
    
error_metabolite(met)=mean(abs((ERROR(met,
:)))); 
end 
error_metabolite(:)=error_metabolite(:)*10
0; 
 
 PlotQmet: plot the same as before but each plot 
represents one metabolite 
 
function 
plotQmet(Q,Qcalc,metabolites,plotcol) 
[MET,J]=size(Q); 
figure 
plotrows=ceil(MET/plotcol); 
for met=1:MET 
    subplot(plotrows,plotcol,met) 
    plot((1:J),Q(met,:),'b'); 
    hold 
    plot((1:J),Qcalc(met,:),'r'); 
    grid on 
    title(metabolites(met)); 
    xlabel('Samples'); 
     
    if strcmp(metabolites(met),'Biomass') 
|| strcmp(metabolites(met),'Cell death') 
        ylabel('Consumption/production 
[1000∑cells/(MVC∑day)]'); 
    else 
        ylabel('Consumption/production 
[nmol/(MVC∑day)]'); 
    end 
    YMAX=max([Q(met,:) Qcalc(met,:)]); 
    YMIN=min([Q(met,:) Qcalc(met,:)]); 
    if YMIN>0 
        AXIS([0 J 0 YMAX+YMAX*0.2]); 
    elseif YMAX<0 
        AXIS([0 J YMIN+YMIN*0.2 0]); 
    else 
  
    end 
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end 
 
 
 Plotevery and ploteverymet use plotQ, plotQ2 and 
plotQmet are used in the program in order to decide the 
number of plots of each figure. 
 
 calctimeline: estimated the concentration over time 
using Eq. 31 and plot this evolution over time for each 
metabolite 
 
function 
[Ccalc,time]=calctimeline(step,days,C0,Are
d,MUred,K,nbio,Q,samples,maxplots,plotcol,
C) 
  
nmetab=length(C0); 
nstep=ceil(days/step); 
time=zeros(1,nstep+1); 
Ccalc=zeros(nmetab,nstep+1); 
NP=ceil(nmetab/maxplots); 
plotrow=ceil(maxplots/plotcol); 
%Calcualtes all the steps excepting the 
last one using Ccalc 
Ccalc(:,1)=C0; 
for i=1:nstep-1 
    
Qcalc=calcrates(Ared,MUred,Ccalc(:,i),K,Q(
:,1)); 
    
Ccalc(:,i+1)=Ccalc(:,i)+Qcalc*Ccalc(nbio,i
)*step/(1000); 
    time(i+1)=i*step; 
end 
%Calculates the final step which can be 
shorter than step 
finalstep=days-time(i+1); 
i=i+1; 
Qcalc=calcrates(Ared,MUred,Ccalc(:,i),K,Q(
:,i)); 
Ccalc(:,nstep+1)=Ccalc(:,i)+Qcalc*Ccalc(nb
io,i)*finalstep/(1000); 
time(i+1)=time(i)+finalstep; 
time1=[0,1]; 
C1=[C0 C]; 
for np=1:NP-1 
    figure 
    for nsubplot=1:maxplots 
        subplot(plotrow,plotcol,nsubplot); 
        plot(time,Ccalc(nsubplot+(np-
1)*maxplots,:),'r'); 
        grid on 
        hold 
        plot(time1,C1(nsubplot+(np-
1)*maxplots,:),'b'); 
        title(samples(nsubplot+(np-
1)*maxplots)); 
        xlabel('Time [days]'); 
        if (strcmp(samples(nsubplot+(np-
1)*maxplots),'Biomass')) || 
(strcmp(samples(nsubplot+(np-
1)*maxplots),'Cell death')) 
            ylabel('Concentration 
[1000∑cells/mL]'); 
        else 
            ylabel('Concentration [mM]'); 
        end 
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    end 
end 
%Plot the last figures which can have less 
graphs 
figure 
  
nsubplot_total=mod(nmetab,maxplots); 
for nsubplot=1:nsubplot_total 
    subplot(plotrow,plotcol,nsubplot); 
    plot(time,Ccalc((NP-
1)*maxplots+nsubplot,:),'r'); 
    grid on 
    hold 
    plot(time1,C1((NP-
1)*maxplots+nsubplot,:),'b'); 
    title(samples((NP-
1)*maxplots+nsubplot)); 
    xlabel('Time [days]'); 
    if (strcmp(samples((NP-
1)*maxplots+nsubplot),'Biomass')) || 
(strcmp(samples((NP-
1)*maxplots+nsubplot),'Cell death')) 
        ylabel('Concentration 
[1000∑cells/mL]'); 
    else 
        ylabel('Concentration [mM]'); 
    end 
end 
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